Keyword Search Results for "coronary"

Hillis, L. D., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial Journal of the American College of Cardiology. 1985;6(5):957-62. Abstract

Williams, D. O., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial Circulation. 1986;73(2):338-46. Abstract

Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Hillis, D., Ludbrook, P., et al., Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation. 1987;76(1):142-54. Abstract

Gore, J. M., Roberts, R., Ball, S. P., Montero, A., Goldberg, R. J., Dalen, J. E. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction American Journal of Cardiology. 1987;59(15):1234-8. Abstract

Holmes, D. R., Jr., Bove, A. A., Nishimura, R. A., Gehring, D. G., Chesebro, J. H., Owen, R. M., Smith, H. C. Comparison of monoplane and biplane assessment of regional left ventricular wall motion after thrombolytic therapy for acute myocardial infarction American Journal of Cardiology. 1987;59(8):793-7. Abstract

Mueller, H. S., Rao, A. K., Forman, S. A. Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator Journal of the American College of Cardiology. 1987;10(3):479-90. Abstract

Passamani, E., Hodges, M., Herman, M., Grose, R., Chaitman, B., Rogers, W., Forman, S., Terrin, M., Knatterud, G., Robertson, T., et al., The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. 1987;10(5 Suppl 2):51B-64B. Abstract

Sheehan, F. H., Braunwald, E., Canner, P., Dodge, H. T., Gore, J., Van Natta, P., Passamani, E. R., Williams, D. O., Zaret, B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial Circulation. 1987;75(4):817-29. Abstract

Williams, D. O., Ruocco, N. A., Forman, S. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1987;10(5 Suppl B):45B-50B. Abstract

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group JAMA. 1988;260:2849-58. Abstract

Dalen, J. E., Gore, J. M., Braunwald, E., Borer, J., Goldberg, R. J., Passamani, E. R., Forman, S., Knatterud, G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial American Journal of Cardiology. 1988;62(4):179-85. Abstract

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27. Abstract

Chaitman, B. R., Thompson, B., Wittry, M. D., Stump, D., Hamilton, W. P., Hillis, L. D., Dwyer, J. G., Solomon, R. E., Knatterud, G. L. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators Journal of the American College of Cardiology. 1989;14(5):1159-65. Abstract

Gibbons, R. J., Verani, M. S., Behrenbeck, T., Pellikka, P. A., O'Connor, M. K., Mahmarian, J. J., Chesebro, J. H., Wackers, F. J. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction Circulation. 1989;80(5):1277-86. Abstract

Gore, J. M., Corrao, J. M., Goldberg, R. J., Ball, S. P., Weiner, B. H., Aghababian, R. V., Dalen, J. E. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction Archives of internal medicine. 1989;149(2):353-5. Abstract

Ong, L., Coromilas, J., Zimmerman, J. M., Green, S., Padmanabhan, V., Reiser, P., Bigger, J. T., Jr., Morrison, J. A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction American Journal of Cardiology. 1989;64(1):5-Nov. Abstract

Wackers, F. J., Terrin, M. L., Kayden, D. S., Knatterud, G., Forman, S., Braunwald, E., Zaret, B. L. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial Journal of the American College of Cardiology. 1989;13(5):998-1005. Abstract

Baim, D. S., Braunwald, E., Feit, F., Knatterud, G. L., Passamani, E. R., Robertson, T. L., Rogers, W. J., Solomon, R. E., Williams, D. O. The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives Journal of the American College of Cardiology. 1990;15(5):1188-92. Abstract

Chaitman, B. R., Thompson, B. W., Kern, M. J., Vandormael, M. G., Cohen, M. B., Ruocco, N. A., Solomon, R. E., Braunwald, E. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators American heart journal. 1990;119(2 Pt 1):213-23. Abstract

Feit, F., Mueller, H. S., Braunwald, E., Ross, R., Hodges, M., Herman, M. V., Knatterud, G. L. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group Journal of the American College of Cardiology. 1990;16(7):1529-34. Abstract

Gertz, S. D., Kalan, J. M., Kragel, A. H., Roberts, W. C., Braunwald, E. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator American Journal of Cardiology. 1990;65(15):953-61. Abstract

Gertz, S. D., Kragel, A. H., Kalan, J. M., Braunwald, E., Roberts, W. C. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators American Journal of Cardiology. 1990;66(12):904-9. Abstract

Hillis, L. D., Forman, S., Braunwald, E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators Journal of the American College of Cardiology. 1990;16(2):313-5. Abstract

Johnson, L. L., Seldin, D. W., Keller, A. M., Wall, R. M., Bhatia, K., Bingham, C. O., 3rd, Tresgallo, M. E. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk Circulation. 1990;81(1):37-45. Abstract

Rogers, W. J., Baim, D. S., Gore, J. M., Brown, B. G., Roberts, R., Williams, D. O., Chesebro, J. H., Babb, J. D., Sheehan, F. H., Wackers, F. J., et al., Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial Circulation. 1990;81(5):1457-76. Abstract

Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al., Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Annals of internal medicine. 1991;115(4):256-65. Abstract

Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991;83:422-37. Abstract

Rogers, W. J., Babb, J. D., Baim, D. S., Chesebro, J. H., Gore, J. M., Roberts, R., Williams, D. O., Frederick, M., Passamani, E. R., Braunwald, E. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators Journal of the American College of Cardiology. 1991;17(5):1007-16. Abstract

Baim, D. S., Diver, D. J., Feit, F., Greenberg, M. A., Holmes, D. R., Weiner, B. H., Williams, D. O., Schweiger, M. J., Brown, B. G., Frederick, M. M., et al., Coronary angioplasty performed within the Thrombolysis in Myocardial Infarction II study Circulation. 1992;85(1):93-105. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Frederick, M. M., Jacobs, A. K., Faxon, D. P. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II Journal of the American College of Cardiology. 1992;20(3):533-40. Abstract

Kleiman, N. S., Terrin, M., Mueller, H., Chaitman, B., Roberts, R., Knatterud, G. L., Solomon, R., McMahon, R. P., Braunwald, E. Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study Journal of the American College of Cardiology. 1992;19(6):1129-35. Abstract

Mueller, H. S., Cohen, L. S., Braunwald, E., Forman, S., Feit, F., Ross, A., Schweiger, M., Cabin, H., Davison, R., Miller, D., et al., Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II Circulation. 1992;85(4):1254-64. Abstract

Ruocco, N. A., Jr., Bergelson, B. A., Jacobs, A. K., Frederick, M. M., Faxon, D. P., Ryan, T. J. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II) Journal of the American College of Cardiology. 1992;20(7):1445-51. Abstract

Tofler, G. H., Muller, J. E., Stone, P. H., Forman, S., Solomon, R. E., Knatterud, G. L., Braunwald, E. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group Journal of the American College of Cardiology. 1992;20(5):1049-55. Abstract

Williams, D. O., Braunwald, E., Knatterud, G., Babb, J., Bresnahan, J., Greenberg, M. A., Raizner, A., Wasserman, A., Robertson, T., Ross, R. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial Circulation. 1992;85(2):533-42. Abstract

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38-52. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Jacobs, A. K., Zaret, B. L., Wackers, F. J., Frederick, M. M., Faxon, D. P. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group American journal of cardiology. 1993;71(13):1148-52. Abstract

Berger, P. B., Ruocco, N. A., Ryan, T. J., Frederick, M. M., Podrid, P. J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial Journal of the American College of Cardiology. 1993;22(7):1773-9. Abstract

Braunwald, E., Cannon, C. P., McCabe, C. H. Use of composite endpoints in thrombolysis trials of acute myocardial infarction American journal of cardiology. 1993;72(19):G3-G12. Abstract

Chaitman, B. R., McMahon, R. P., Terrin, M., Younis, L. T., Shaw, L. J., Weiner, D. A., Frederick, M. M., Knatterud, G. L., Sopko, G., Braunwald, E. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial American journal of cardiology. 1993;71(2):131-8. Abstract

Lehmann, K. G., Francis, C. K., Sheehan, F. H., Dodge, H. T. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1993;22(3):714-9. Abstract

Taylor, H. A., Chaitman, B. R., Rogers, W. J., Kern, M. J., Terrin, M. L., Aguirre, F. V., Sopko, G., McMahon, R., Ross, R. N., Bovill, E. C. Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial Circulation. 1993;88(4 Pt 1):1484-94. Abstract

Terrin, M. L., Williams, D. O., Kleiman, N. S., Willerson, J., Mueller, H. S., Desvigne-Nickens, P., Forman, S. A., Knatterud, G. L., Braunwald, E. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial Journal of the American College of Cardiology. 1993;22(7):1763-72. Abstract

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation. 1994;89:1545-56. Abstract

Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P., Hamilton, W. P., Chaitman, B. R. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators Circulation. 1994;90(1):78-86. Abstract

Becker, R. C., Cannon, C. P. Hirudin: Its Biology and Clinical Use J Thromb Thrombolysis. 1994;1(1):16-Jul. Abstract

Becker, R. C., Terrin, M., Ross, R., Knatterud, G. L., Desvigne-Nickens, P., Gore, J. M., Braunwald, E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators Annals of internal medicine. 1994;120(8):638-45. Abstract

Becker, R. C., Tracy, R. P., Bovill, E. G., Corrao, J. M., Baker, S., Ball, S. P., Mann, K. G. Surface 12-Lead Electrocardiographic Findings and Plasma Markers of Thrombin Activity and Generation in Patients with Myocardial Ischemia at Rest Journal of thrombosis and thrombolysis. 1994;1(1):101-107. Abstract

Cannon CP, McCabe CH, Henry TD, Schweiger MJ, Gibson RS, Mueller HS, Becker RC, Kleiman NS, Haugland JM, Anderson JL, et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol. 1994;23:993-1003. Abstract

Cannon, C. P., Antman, E. M., Walls, R., Braunwald, E. Time as an Adjunctive Agent to Thrombolytic Therapy J Thromb Thrombolysis. 1994;1(1):27-34. Abstract

Cannon, C. P., McCabe, C. H., Diver, D. J., Herson, S., Greene, R. M., Shah, P. K., Sequeira, R. F., Leya, F., Kirshenbaum, J. M., Magorien, R. D., et al., Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial J Am Coll Cardiol. 1994;24:1602-10. Abstract

Cox, D. A., Rogers, W. J., Aguirre, F. V., Forman, S., Solomon, R., Zaret, B. L. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators American journal of cardiology. 1994;73(11):729-36. Abstract

Diver, D. J., Bier, J. D., Ferreira, P. E., Sharaf, B. L., McCabe, C., Thompson, B., Chaitman, B., Williams, D. O., Braunwald, E. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial) American journal of cardiology. 1994;74(6):531-7. Abstract

Schweiger, M. J., McMahon, R. P., Terrin, M. L., Ruocco, N. A., Porway, M. N., Wiseman, A. H., Knatterud, G. L., Braunwald, E. Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators American journal of cardiology. 1994;74(2):105-10. Abstract

Aguirre, F. V., Younis, L. T., Chaitman, B. R., Ross, A. M., McMahon, R. P., Kern, M. J., Berger, P. B., Sopko, G., Rogers, W. J., Shaw, L., et al., Early and 1-year clinical outcome of patients' evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis. Results from The TIMI II Study Circulation. 1995;91(10):2541-8. Abstract

Anderson, H. V., Cannon, C. P., Stone, P. H., Williams, D. O., McCabe, C. H., Knatterud, G. L., Thompson, B., Willerson, J. T., Braunwald, E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction Journal of the American College of Cardiology. 1995;26(7):1643-50. Abstract

Cannon, C. P., Thompson, B., McCabe, C. H., Mueller, H. S., Kirshenbaum, J. M., Herson, S., Nasmith, J. B., Chaitman, B. R., Braunwald, E. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials American journal of cardiology. 1995;75(15):977-81. Abstract

Fuchs J, Cannon CP. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation. 1995;92:727-33. Abstract

Gersh, B. J., Chesebro, J. H., Braunwald, E., Lambrew, C., Passamani, E., Solomon, R. E., Ross, A. M., Ross, R., Terrin, M. L., Knatterud, G. L. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II) Journal of the American College of Cardiology. 1995;25(2):395-402. Abstract

Gibson, C. M., Cannon, C. P., Piana, R. N., Breall, J. A., Sharaf, B., Flatley, M., Alexander, B., Diver, D. J., McCabe, C. H., Flaker, G. C., et al., Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial Journal of the American College of Cardiology. 1995;25(3):582-9. Abstract

Hall, C., Cannon, C. P., Forman, S., Braunwald, E. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators Journal of the American College of Cardiology. 1995;26(6):1452-6. Abstract

Kloner, R. A., Shook, T., Przyklenk, K., Davis, V. G., Junio, L., Matthews, R. V., Burstein, S., Gibson, M., Poole, W. K., Cannon, C. P., et al., Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation. 1995;91(1):37-45. Abstract

Lee, LV. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial Am J Cardiol. 1995;75:7-13. Abstract

McKendall, G. R., Forman, S., Sopko, G., Braunwald, E., Williams, D. O. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators American Journal of Cardiology. 1995;76(16):1108-11. Abstract

Mueller, Hiltrud S., Forman, Sandra A., Menegus, Mark A., Cohen, Lawrence S., Knatterud, Genell L., Braunwald, Eugene Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial Journal of the American College of Cardiology. 1995;26(4):900-907.

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Davis, V., Braunwald, E., Shah, P. K. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial) American journal of cardiology. 1995;75(4):232-6. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Shah, P. K. Thrombolytic Therapy for Acute Myocardial Infarction in Patients with Prior Coronary Bypass Surgery: Results from the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial Journal of thrombosis and thrombolysis. 1995;2(1):45-50. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Forman, S. A., Williams, D. O., Knatterud, G. L., Braunwald, E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group Journal of the American College of Cardiology. 1995;26(1):73-9. Abstract

Antman, E. M. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial Circulation. 1996;94:911-21. Abstract

Becker, R. C., Cannon, C. P., Bovill, E. G., Tracy, R. P., Thompson, B., Knatterud, G. L., Randall, A., Braunwald, B. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) American journal of cardiology. 1996;78(2):142-7. Abstract

Becker, R. C., Cannon, C. P., Tracy, R. P., Thompson, B., Bovill, E. G., Desvigne-Nickens, P., Randall, A. M., Knatternud, G., Braunwald, E. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators American heart journal. 1996;131(3):421-33. Abstract

Birnbaum, Y., Kloner, R. A., Sclarovsky, S., Cannon, C. P., McCabe, C. H., Davis, V. G., Zaret, B. L., Wackers, F. J., Braunwald, E. Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial) American journal of cardiology. 1996;78(4):396-403. Abstract

Gibson, C. M., Cannon, C. P., Daley, W. L., Dodge, J. T., Jr., Alexander, B., Jr., Marble, S. J., McCabe, C. H., Raymond, L., Fortin, T., Poole, W. K., Braunwald, E. TIMI frame count: a quantitative method of assessing coronary artery flow Circulation. 1996;93(5):879-88. Abstract

Kleiman, N. S., Anderson, H. V., Rogers, W. J., Theroux, P., Thompson, B., Stone, P. H. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry) American journal of cardiology. 1996;77(4):227-31. Abstract

Scharfstein, J. S., Abendschein, D. R., Eisenberg, P. R., George, D., Cannon, C. P., Becker, R. C., Sobel, B., Cupples, L. A., Braunwald, E., Loscalzo, J. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction American journal of cardiology. 1996;78(5):503-10. Abstract

Williams, D. O., Braunwald, E., Thompson, B., Sharaf, B. L., Buller, C. E., Knatterud, G. L. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial Circulation. 1996;94(11):2749-55. Abstract

Cannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy RP, Love TW, Braunwald E. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation. 1997;95:351-6. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Rogers, W. J., Schactman, M., Thompson, B. W., Pearce, D. J., Diver, D. J., Kells, C., Feldman, T., Williams, M., Gibson, R. S., Kronenberg, M. W., Ganz, L. I., Anderson, H. V., Braunwald, E. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia Journal of the American College of Cardiology. 1997;30(1):133-40. Abstract

Cannon, C. P., Sharis, P. J., Schweiger, M. J., McCabe, C. H., Diver, D. J., Shah, P. K., Sequeira, R. F., Greene, R. M., Perritt, R. L., Poole, W. K., Braunwald, E. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction American journal of cardiology. 1997;80(6):696-9. Abstract

Gibson, C. M., Cannon, C. P., Greene, R. M., Sequeira, R. F., Margorien, R. D., Leya, F., Diver, D. J., Baim, D. S., Braunwald, E. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial American journal of cardiology. 1997;80(1):21-6. Abstract

Gibson, C. M., Marble, S. J., Rizzo, M. J., Moynihan, J., McLean, C., Ryan, K., Sparano, A., Piana, R. N., McCabe, C., Cannon, C. P. Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trial American heart journal. 1997;134(3):351-4. Abstract

Hochman, J. S., McCabe, C. H., Stone, P. H., Becker, R. C., Cannon, C. P., DeFeo-Fraulini, T., Thompson, B., Steingart, R., Knatterud, G., Braunwald, E. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction Journal of the American College of Cardiology. 1997;30(1):141-8. Abstract

Jain, D., Thompson, B., Wackers, F. J., Zaret, B. L. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study Journal of the American College of Cardiology. 1997;30(2):421-9. Abstract

Sloan, M. A., Price, T. R., Terrin, M. L., Forman, S., Gore, J. M., Chaitman, B. R., Hodges, M., Mueller, H., Rogers, W. J., Knatterud, G. L., Braunwald, E. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience Stroke. 1997;28(6):1107-14. Abstract

Antman, E. M. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators Am Heart J. 1998;135(6, Supplement 2):S353-60. Abstract

Antman, E. M., Sacks, D. B., Rifai, N., McCabe, C. H., Cannon, C. P., Braunwald, E. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy J Am Coll Cardiol. 1998;31(2):326-30. Abstract

Borzak, S., Cannon, C. P., Kraft, P. L., Douthat, L., Becker, R. C., Palmeri, S. T., Henry, T., Hochman, J. S., Fuchs, J., Antman, E. M., McCabe, C., Braunwald, E. Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia American journal of cardiology. 1998;81(6):678-81. Abstract

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation. 1998;98:2805-14. Abstract

Cannon CP, McCabe CH, Borzak S, Henry TD, Tischler MD, Mueller HS, Feldman R, Palmeri ST, Ault K, Hamilton SA, Rothman JM, Novotny WF, Braunwald E. Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Circulation. 1998;97:340-9. Abstract

Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Robertson, D. H., Gormley, G. J., Braunwald, E. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction Am J Cardiol. 1998;82(6):731-6. Abstract

Kloner, R. A., Przyklenk, K., Shook, T., Cannon, C. P. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial Journal of thrombosis and thrombolysis. 1998;6(2):89-92. Abstract

Kloner, R. A., Shook, T., Antman, E. M., Cannon, C. P., Przyklenk, K., Yoo, K., McCabe, C. H., Braunwald, E. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B Circulation. 1998;97(11):1042-5. Abstract

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., Braunwald, E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1998;31(7):1460-5. Abstract

Sagarin, M. J., Cannon, C. P., Cermignani, M. S., Scirica, B. M., Walls, R. M. Delay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effect J Emerg Med. 1998;16(4):557-65. Abstract

Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation. 1999;100:1593-601. Abstract

Antman, E. M., Cohen, M., Radley, D., McCabe, C., Rush, J., Premmereur, J., Braunwald, E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis Circulation. 1999;100(15):1602-8. Abstract

Becker, R. C., Hochman, J. S., Cannon, C. P., Spencer, F. A., Ball, S. P., Rizzo, M. J., Antman, E. M. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study Journal of the American College of Cardiology. 1999;33(2):479-87. Abstract

Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. Am Heart J. 1999;137:1179-84. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Adgey, A. A., Schweiger, M. J., Sequeira, R. F., Grollier, G., Fox, N. L., Berioli, S., Weaver, W. D., Van de Werf, F., Braunwald, E. Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators Am J Cardiol. 1999;84(9):976-80. Abstract

Gibson, C. M., Murphy, S., Menown, I. B., Sequeira, R. F., Greene, R., Van de Werf, F., Schweiger, M. J., Ghali, M., Frey, M. J., Ryan, K. A., Marble, S. J., Giugliano, R. P., Antman, E. M., Cannon, C. P., Braunwald, E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1999;34(5):1403-12. Abstract

Kizer, J. R., Cannon, C. P., McCabe, C. H., Mueller, H. S., Schweiger, M. J., Davis, V. G., Perritt, R., Antman, E. M. Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction American heart journal. 1999;137(1):79-92. Abstract

Stone, P. H., Thompson, B., Zaret, B. L., Chaitman, B., Gibson, R. S., Schweiger, M. J., Steingart, R., Kirshenbaum, J., Thompson, C., Fung, A., McCabe, C. H., Knatterud, G. L., Braunwald, E. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study European heart journal. 1999;20(15):1084-93. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease Clinical cardiology. 1999;22(1):13-6. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Braunwald, E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B J Am Coll Cardiol. 1999;34(3):739-47. Abstract

Van de Werf, F., Cannon, C. P., Luyten, A., Houbracken, K., McCabe, C. H., Berioli, S., Bluhmki, E., Sarelin, H., Wang-Clow, F., Fox, N. L., Braunwald, E. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators Am Heart J. 1999;137(5):786-91. Abstract

Antman, E. M., Cohen, M., Bernink, P. J., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., Braunwald, E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA. 2000;284(7):835-42. Abstract

Antman, E. M., Gibson, C. M., de Lemos, J. A., Giugliano, R. P., McCabe, C. H., Coussement, P., Menown, I., Nienaber, C. A., Rehders, T. C., Frey, M. J., Van der Wieken, R., Andresen, D., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators Eur Heart J. 2000;21(23):1944-53. Abstract

Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E., Gibson, C. M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy Circulation. 2000;102(19):2329-34. Abstract

Cannon CP, McCabe CH, Wilcox RG, Langer A, Caspi A, Berink P, Lopez-Sendon J, Toman J, Charlesworth A, Anders RJ, Alexander JC, Skene A, Braunwald E. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation. 2000;102:149-56. Abstract

Cannon, C. P. Learning from the recently completed oral glycoprotein IIb/IIIa receptor antagonist trials Clin Cardiol. 2000;23 Suppl 6(NA):VI-14-7. Abstract

Cannon, C. P. Bridging the gap with new strategies in acute ST elevation myocardial infarction: bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI J Thromb Thrombolysis. 2000;9(3):235-41. Abstract

Cannon, C. P., Sayah, A. J., Walls, R. M. ER TIMI-19: testing the reality of prehospital thrombolysis J Emerg Med. 2000;19(3 Suppl):21S-25S.

Cohen, M., Antman, E. M., Gurfinkel, E., Turpie, A. G., Furst, J., Bigonzi, F., Radley, D. Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction Am J Cardiol. 2000;86(5):553-6, A9. Abstract

Gibson, C. M., Anshelevich, M., Murphy, S., Luu, L., Hynes, C., Kliris, J., Kermgard, S., Otten, M. H., Antman, E. M., Cannon, C. P., Braunwald, E. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction Am J Cardiol. 2000;86(12):1378-9, A5. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Ryan, K. A., Mesley, R., Marble, S. J., McCabe, C. H., Van De Werf, F., Braunwald, E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation. 2000;101(2):125-30. Abstract

Giugliano RP, McCabe CH, Sequeira RF, Frey MJ, Henry TD, Piana RN, Tamby JF, Jensen BK, Nicolas SB, Jennings LK, Wise RJ, Braunwald E. First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials. Am Heart J. 2000;140:81-93. Abstract

Holmes, M. B., Sobel, B. E., Cannon, C. P., Schneider, D. J. Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial Infarction Am J Cardiol. 2000;85(4):491-3, A10. Abstract

Llevadot, J., Giugliano, R. P., McCabe, C. H., Cannon, C. P., Antman, E. M., Murphy, S., Gibson, C. M. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials) Am J Cardiol. 2000;85(12):1409-13. Abstract

Morrow, D. A., Antman, E. M., Tanasijevic, M., Rifai, N., de Lemos, J. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy J Am Coll Cardiol. 2000;36(6):1812-7. Abstract

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., Braunwald, E. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy J Am Coll Cardiol. 2000;35(2):358-62. Abstract

The InTIMI-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005-13. Abstract

de Lemos, J. A., Antman, E. M., Gibson, C. M., McCabe, C. H., Giugliano, R. P., Murphy, S. A., Coulter, S. A., Anderson, K., Scherer, J., Frey, M. J., Van Der Wieken, R., Van De Werf, F., Braunwald, E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial Circulation. 2000;101(3):239-43. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., McCabe, C. H., Murphy, S. A., Van de Werf, F., Gibson, C. M., Braunwald, E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators Am J Cardiol. 2000;85(3):299-304. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Charlesworth, A., Schroder, R., Braunwald, E. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram Am Heart J. 2000;140(3):373-8. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Cutler, S. S., Charlesworth, A., Schroder, R., Braunwald, E. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II Am J Cardiol. 2000;86(11):1235-7, A5. Abstract

de Lemos, J. A., Antman, E. M., Morrow, D. A., Llevadot, J., Giugliano, R. P., Coulter, S. A., Schuhwerk, K. C., Arslanian, S., McCabe, C. H., Gibson, C. M., Rifai, N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy Clin Chim Acta. 2000;298(2-Jan):85-97. Abstract

Blazing, M. A., De Lemos, J. A., Dyke, C. K., Califf, R. M., Bilheimer, D., Braunwald, E. The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy Am Heart J. 2001;142(2):211-7.

Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87. Abstract

Cohen, M., Antman, E. M., Gurfinkel, E. P., Radley, D. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups J Thromb Thrombolysis. 2001;12(3):199-206. Abstract

Gibson, C. M., Kirtane, A. J., Murphy, S. A., Marble, S. J., de Lemos, J. A., Antman, E. M., Braunwald, E. Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction Catheter Cardiovasc Interv. 2001;53(1):11-Jun. Abstract

Gibson, C. M., Murphy, S. A., Marble, S. J., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group Am J Cardiol. 2001;87(4):450-3, A6. Abstract

Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4. Abstract

Giugliano, R. P., Llevadot, J., Wilcox, R. G., Gurfinkel, E. P., McCabe, C. H., Charlesworth, A., Thompson, S. L., Antman, E. M., Braunwald, E. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur Heart J. 2001;22(18):1702-15. Abstract

Llevadot, J., Giugliano, R. P., Antman, E. M., Wilcox, R. G., Gurfinkel, E. P., Henry, T., McCabe, C. H., Charlesworth, A., Thompson, S., Nicolau, J. C., Tebbe, U., Sadowski, Z., Braunwald, E. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction Eur Heart J. 2001;22(22):2104-15. Abstract

Morrow, D. A., Cannon, C. P., Rifai, N., Frey, M. J., Vicari, R., Lakkis, N., Robertson, D. H., Hille, D. A., DeLucca, P. T., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA. 2001;286(19):2405-12. Abstract

Roe, Matthew T., Giugliano, Robert P., Harrington, Robert A., Gibson, C. Michael, Strony, John, Kitt, Michael M., Califf, Robert M., Braunwald, Eugene Combination reperfusion therapy with eptifibatide and tenecteplase for acute myocardial infarction. Design and methodology of the INTEGRITI (Integrilin and Tenecteplase for Acute Myocardial Infarction) trial HeartDrug. 2001;1(1):13-May.

Santopinto, J., Gurfinkel, E. P., Torres, V., Marcos, E., Bozovich, G. E., Mautner, B., McCabe, C. H., Antman, E. M. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin Am Heart J. 2001;141(4):566-72. Abstract

Schweiger, M. J., Cannon, C. P., Murphy, S. A., Gibson, C. M., Cook, J. R., Giugliano, R. P., Changezi, H. U., Antman, E. M., Braunwald, E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience) Am J Cardiol. 2001;88(8):831-6. Abstract

Solomon, D. H., Stone, P. H., Glynn, R. J., Ganz, D. A., Gibson, C. M., Tracy, R., Avorn, J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Journal of the American College of Cardiology. 2001;38(4):969-76. Abstract

Wang-Clow, F., Fox, N. L., Cannon, C. P., Gibson, C. M., Berioli, S., Bluhmki, E., Danays, T., Braunwald, E., Van De Werf, F., Stump, D. C. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator Am Heart J. 2001;141(1):33-40. Abstract

de Lemos, J. A., Gibson, C. M., Antman, E. M., Murphy, S. A., Morrow, D. A., Schuhwerk, K. C., Schweiger, M., Coussement, P., Van de Werf, F., Braunwald, E. Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial Am Heart J. 2001;141(4):592-8. Abstract

de Lemos, J. A., Morrow, D. A., Bentley, J. H., Omland, T., Sabatine, M. S., McCabe, C. H., Hall, C., Cannon, C. P., Braunwald, E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med. 2001;345(14):1014-21. Abstract

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Rifai, N., Tanasijevic, M., Giugliano, R. P., Schuhwerk, K. C., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy Am J Cardiol. 2001;88(4):353-8. Abstract

Angeja, B. G., Kermgard, S., Chen, M. S., McKay, M., Murphy, S. A., Antman, E. M., Cannon, C. P., Braunwald, E., Gibson, C. M. The smoker's paradox: insights from the angiographic substudies of the TIMI trials J Thromb Thrombolysis. 2002;13(3):133-9. Abstract

Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, Bigonzi F, Pisapia G, Gibson CM, Heidbuchel H, Braunwald E, Van de Werf F. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation. 2002;105:1642-9.

Antman EM, McCabe CH, Braunwald E. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002;143:229-34. Abstract

Antman, E. M., Cohen, M., McCabe, C., Goodman, S. G., Murphy, S. A., Braunwald, E. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE Eur Heart J. 2002;23(4):308-14. Abstract

Antman, E. M., Cooper, H. A., Gibson, C. M., de Lemos, J. A., McCabe, C. H., Giugliano, R. P., Coussement, P., Murphy, S., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II Eur Heart J. 2002;23(12):928-33. Abstract

Brener, S. J., Murphy, S. A., Gibson, C. M., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P. Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes Am J Cardiol. 2002;90(6):631-3.

Cohen, M., Antman, E. M., Murphy, S. A., Radley, D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes Am Heart J. 2002;143(1):63-9. Abstract

Fox, K. A., Antman, E. M., Cohen, M., Bigonzi, F. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention Am J Cardiol. 2002;90(5):477-82. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Marble, S. J., Barron, H. V., Braunwald, E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation. 2002;105(16):1909-13. Abstract

Gibson, C. M., Chen, M., Angeja, B. G., Murphy, S. A., Marble, S. J., Barron, H. V., Cannon, C. P. Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery J Thromb Thrombolysis. 2002;13(1):12-Sep. Abstract

Glaser, R., Herrmann, H. C., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Braunwald, E. Benefit of an early invasive management strategy in women with acute coronary syndromes JAMA. 2002;288(24):3124-9.

Januzzi, J. L., Cannon, C. P., DiBattiste, P. M., Murphy, S., Weintraub, W., Braunwald, E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial) Am J Cardiol. 2002;90(11):1246-9.

Kenny, D., Muckian, C., Fitzgerald, D. J., Cannon, C. P., Shields, D. C. Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients J Thromb Thrombolysis. 2002;13(1):13-9. Abstract

Lakkis, N., Tsyboulev, V., Gibson, C. M., Murphy, S. A., Weintraub, W. S., DiBattiste, P. M., Cannon, C. P. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2002;1(4):232-7.

Morrow DA, Antman EM, Sayah A, Schuhwerk KC, Giugliano RP, deLemos JA, Waller M, Cohen SA, Rosenberg DG, Cutler SS, McCabe CH, Walls RM, Braunwald E. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol. 2002;40:71-7.

Morrow, D. A., Antman, E. M., Snapinn, S. M., McCabe, C. H., Theroux, P., Braunwald, E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS Eur Heart J. 2002;23(3):223-9. Abstract

NA, NA Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data Lancet. 2002;359(9303):294-302. Abstract

Sabatine, M. S., Morrow, D. A., Cannon, C. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Braunwald, E., Gibson, C. M. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy J Am Coll Cardiol. 2002;40(10):1761-8.

Wong, G. C., Morrow, D. A., Murphy, S., Kraimer, N., Pai, R., James, D., Robertson, D. H., Demopoulos, L. A., DiBattiste, P., Cannon, C. P., Gibson, C. M. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction Circulation. 2002;106(2):202-7.

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Sabatine, M. S., Rifai, N., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies J Am Coll Cardiol. 2002;40(2):238-44. Abstract

Cannon, C. P. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial J Am Coll Cardiol. 2003;41(4 Suppl S):43S-48S. Abstract

Cannon, C. P. The next step in cardiovascular protection Atheroscler Suppl. 2003;4(5):9-Mar. Abstract

Christenson, R. H., Leino, E. V., Giugliano, R. P., Bahr, R. D. Usefulness of prodromal unstable angina pectoris in predicting better survival and smaller infarct size in acute myocardial infarction (The InTIME-II Prodromal Symptoms Substudy) Am J Cardiol. 2003;92(5):598-600. Abstract

Cotter, G., Cannon, C. P., McCabe, C. H., Michowitz, Y., Kaluski, E., Charlesworth, A., Milo, O., Bentley, J., Blatt, A., Krakover, R., Zimlichman, R., Reisin, L., Marmor, A., Lewis, B., Vered, Z., Caspi, A., Braunwald, E. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study Am Heart J. 2003;145(4):622-7. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., James, D., Morrow, D. A., Cannon, C. P., Giugliano, R. P., Antman, E. M., Braunwald, E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials J Am Coll Cardiol. 2003;42(1):16-Jul. Abstract

Gibson, C. M., Pinto, D. S., Murphy, S. A., Morrow, D. A., Hobbach, H. P., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol. 2003;42(9):1535-43. Abstract

Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, Baran KW, Hobbach HP, Woodlief LH, Hannan KL, Greenberg S, Miller J, Kitt MM, Strony J, McCabe CH, Braunwald E, Califf RM. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol. 2003;41:1251-60.

Karha, J., Murphy, S. A., Kirtane, A. J., de Lemos, J. A., Aroesty, J. M., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction Am J Cardiol. 2003;92(8):913-8. Abstract

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Gibson, C. M., Cannon, C. P., Braunwald, E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol. 2003;41(8):1264-72.

Pinto, D. S., Lorenz, D. P., Murphy, S. A., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Gibson, C. M. Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2003;91(8):976-8, A4.

Serrano, C. V., Jr., Nicolau, J. C., Venturinelli, M., Baracioli, L. M., Anders, R. J., Cannon, C. P., Ramires, J. A. Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes Cardiovasc Drugs Ther. 2003;17(2):129-32. Abstract

Spinler, S. A., Inverso, S. M., Cohen, M., Goodman, S. G., Stringer, K. A., Antman, E. M. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies Am Heart J. 2003;146(1):33-41. Abstract

Wong, G. C., Frisch, D., Murphy, S. A., Sabatine, M. S., Pai, R., James, D., Kraimer, N., Katsiyiannis, P. T., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Gourlay, S. G., Barron, H. V., Cannon, C. P., Gibson, C. M. Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction Am J Cardiol. 2003;91(10):1163-7.

Bach, R. G., Cannon, C. P., Weintraub, W. S., DiBattiste, P. M., Demopoulos, L. A., Anderson, H. V., DeLucca, P. T., Mahoney, E. M., Murphy, S. A., Braunwald, E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes Ann Intern Med. 2004;141(3):186-95.

Blazing MA, de Lemos JA, White HD, Fox KA, Verheugt FW, Ardissino D, DiBattiste PM, Palmisano J, Bilheimer DW, Snapinn SM, Ramsey KE, Gardner LH, Hasselblad V, Pfeffer MA, Lewis EF, Braunwald E, Califf RM. Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. JAMA. 2004;292:55-64.

Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-504.

Gibson, C. M., Bigelow, B., James, D., Tepper, M. R., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction Am J Cardiol. 2004;94(1):108-11. Abstract

Gibson, C. M., Dumaine, R. L., Gelfand, E. V., Murphy, S. A., Morrow, D. A., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials Eur Heart J. 2004;25(22):1998-2005. Abstract

Gibson, C. M., Jennings, L. K., Murphy, S. A., Lorenz, D. P., Giugliano, R. P., Harrington, R. A., Cholera, S., Krishnan, R., Califf, R. M., Braunwald, E. Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy Circulation. 2004;110(6):679-84.

Gibson, C. M., Karha, J., Giugliano, R. P., Roe, M. T., Murphy, S. A., Harrington, R. A., Green, C. L., Schweiger, M. J., Miklin, J. S., Baran, K. W., Palmeri, S., Braunwald, E., Krucoff, M. W. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction Am Heart J. 2004;147(5):847-52.

Gibson, C. M., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(5):980-7. Abstract

Gibson, C. M., Murphy, S. A., Morrow, D. A., Aroesty, J. M., Gibbons, R. J., Gourlay, S. G., Barron, H. V., Giugliano, R. P., Antman, E. M., Braunwald, E. Angiographic perfusion score: An angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction American Heart Journal. 2004;148(2):336-340. Abstract

Gibson, C. M., Singh, K. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Braunwald, E. Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2004;94(4):492-4. Abstract

Herrmann, H. C., Murphy, S. A., Dibattiste, P. M., Delucca, P. T., Demopoulos, L. A., Gibson, C. M., Cannon, C. P. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2004;3(2):95-100.

Karha, J., Gibson, C. M., Murphy, S. A., Dibattiste, P. M., Cannon, C. P. Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction Am J Cardiol. 2004;94(12):1537-9. Abstract

Karmpaliotis, D., Turakhia, M. P., Kirtane, A. J., Murphy, S. A., Kosmidou, I., Morrow, D. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction Am J Cardiol. 2004;94(9):1113-7. Abstract

McCullough, P. A., Gibson, C. M., Dibattiste, P. M., Demopoulos, L. A., Murphy, S. A., Weintraub, W. S., Neumann, F. J., Khanal, S., Cannon, C. P. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial J Interv Cardiol. 2004;17(2):81-6.

Mega, J. L., Morrow, D. A., De Lemos, J. A., Sabatine, M. S., Murphy, S. A., Rifai, N., Gibson, C. M., Antman, E. M., Braunwald, E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol. 2004;44(2):335-9. Abstract

Morrow, D. A., Antman, E. M., Murphy, S. A., Assmann, S. F., Giugliano, R. P., Cannon, C. P., Michael Gibson, C., McCabe, C. H., Barron, H. V., Van De Werf, F., Braunwald, E. The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies Eur Heart J. 2004;25(13):1139-45. Abstract

Morrow, D. A., Sabatine, M. S., Antman, E. M., Cannon, C. P., Braunwald, E., Theroux, P. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS) Am J Cardiol. 2004;94(6):774-6. Abstract

Ray, K. K., Cannon, C. P. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology Curr Opin Lipidol. 2004;15(6):637-43. Abstract

Roe, M. T., Green, C. L., Giugliano, R. P., Gibson, C. M., Baran, K., Greenberg, M., Palmeri, S. T., Crater, S., Trollinger, K., Hannan, K., Harrington, R. A., Krucoff, M. W. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;43(4):549-56.

Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., Weintraub, W. S., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction - A Comparison of the Thrombolysis in Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial Circulation. 2004;109(7):874-880. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Omland, T., Desai, M. Y., Tanasijevic, M., Hall, C., McCabe, C. H., Braunwald, E. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia J Am Coll Cardiol. 2004;44(10):1988-95. Abstract

Sadanandan, S., Cannon, C. P., Chekuri, K., Murphy, S. A., Dibattiste, P. M., Morrow, D. A., de Lemos, J. A., Braunwald, E., Gibson, C. M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(3):564-8. Abstract

Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., Lee, R. T. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation. 2004;109(18):2186-90. Abstract

Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., Sabatine, M. S., Rifai, N., Giugliano, R. P., DiBattiste, P. M., Demopoulos, L. A., Antman, E. M., Braunwald, E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy Circulation. 2004;109(5):580-6.

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Giugliano, R. P., Gibson, C. M., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):783-9. Abstract

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Brady, W. E., White, H. D., Fox, K. A., Palmisano, J., Ramsey, K. E., Bilheimer, D. W., Lewis, E. F., Pfeffer, M., Califf, R. M., Braunwald, E. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial Eur Heart J. 2004;25(19):1688-94.

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A., White, H. D., Rouleau, J. L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., Ramsey, K. E., Palmisano, J., Bilheimer, D. W., Pfeffer, M. A., Califf, R. M., Braunwald, E. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA. 2004;292(11):1307-16.

ADVANCE MI Investigators Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial Am Heart J. 2005;150(1):116-22.

Ferguson, J. J. Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy--CLARITY-TIMI 28 Future Cardiol. 2005;1(5):605-10. Abstract

Gibson, C. M., Kirtane, A. J., Boundy, K., Ly, H., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients J Am Coll Cardiol. 2005;45(3):357-62. Abstract

Giugliano, R. P., Newby, L. K., Harrington, R. A., Gibson, C. M., Van de Werf, F., Armstrong, P., Montalescot, G., Gilbert, J., Strony, J. T., Califf, R. M., Braunwald, E. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale Am Heart J. 2005;149(6):994-1002. Abstract

Januzzi, J. L., Jr., Buros, J., Cannon, C. P. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial Clin Cardiol. 2005;28(5):238-42.

Kirtane, A. J., Kosmidou, I., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy Am J Cardiol. 2005;95(3):337-42. Abstract

Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., Karmpaliotis, D., Burger, A. J., Murphy, S. A., Cannon, C. P., Braunwald, E., Gibson, C. M. Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates J Am Coll Cardiol. 2005;45(11):1781-6. Abstract

Kirtane, A. J., Weisbord, A., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Ohman, E. M., Roe, M. T., Braunwald, E., Gibson, C. M. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction Am J Cardiol. 2005;95(2):224-7. Abstract

Ly, H. Q., Kirtane, A. J., Buros, J., Giugliano, R. P., Popma, J. J., Antman, E. M., Harrington, R. A., Ohman, E. M., Gibson, C. M. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(3):383-6. Abstract

Mega, J. L., Morrow, D. A., Sabatine, M. S., Zhao, X. Q., Snapinn, S. M., DiBattiste, P. M., Gibson, C. M., Antman, E. M., Braunwald, E., Theroux, P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Am Heart J. 2005;149(5):846-50. Abstract

Ray, K. K., Cannon, C. P. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes J Am Coll Cardiol. 2005;46(8):1425-33. Abstract

Ray, K. K., Cannon, C. P. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? Am J Cardiol. 2005;96(5A):54F-60F. Abstract

Sabatine, M. S., Blake, G. J., Drazner, M. H., Morrow, D. A., Scirica, B. M., Murphy, S. A., McCabe, C. H., Weintraub, W. S., Gibson, C. M., Cannon, C. P. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment Circulation. 2005;111(10):1217-24.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., McCabe, C. H., Braunwald, E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med. 2005;352(12):1179-89.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Lewis, B. S., Murphy, S. A., McCabe, C. H., Braunwald, E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA. 2005;294(10):1224-32.

Sabatine, M. S., McCabe, C. H., Gibson, C. M., Cannon, C. P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial Am Heart J. 2005;149(2):227-33.

Sabatine, M. S., Morrow, D. A., Montalescot, G., Dellborg, M., Leiva-Pons, J. L., Keltai, M., Murphy, S. A., McCabe, C. H., Gibson, C. M., Cannon, C. P., Antman, E. M., Braunwald, E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial Circulation. 2005;112(25):3846-54.

Smith, C. S., Cannon, C. P., McCabe, C. H., Murphy, S. A., Bentley, J., Braunwald, E. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial Am Heart J. 2005;149(3):444-50. Abstract

Steinberg, B. A., Braganza, A. J., Eminowicz, G., Dibattiste, P. M., Flaker, G. C., Murphy, S. A., Cannon, C. P. Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18 Crit Pathw Cardiol. 2005;4(4):169-73. Abstract

Ahmed, S., Cannon, C. P., Murphy, S. A., Braunwald, E. Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial Eur Heart J. 2006;27(19):2323-9.

Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., Lopez-Sendon, J. L., Guneri, S., Jiang, F., White, H. D., Fox, K. A., Braunwald, E. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction N Engl J Med. 2006;354(14):1477-88.

Bhadriraju, S., Ray, K. K., DeFranco, A. C., Barber, K., Bhadriraju, P., Murphy, S. A., Morrow, D. A., McCabe, C. H., Gibson, C. M., Cannon, C. P., Braunwald, E. Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial Am J Cardiol. 2006;97(11):1573-7. Abstract

Cannon, C. P., Curtis, S. P., Bolognese, J. A., Laine, L. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis Am Heart J. 2006;152(2):237-45. Abstract

Cannon, C. P., McLean, D. S. Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapy Am J Cardiol. 2006;98(10A):33N-38N. Abstract

Cannon, C. P., Steinberg, B. A., Murphy, S. A., Mega, J. L., Braunwald, E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol. 2006;48(3):438-45. Abstract

Charytan, D., Mauri, L., Agarwal, A., Servoss, S., Scirica, B., Kuntz, R. E. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients Am Heart J. 2006;152(3):558-64. Abstract

Dumaine, R., Gibson, C. M., Murphy, S. A., Southard, M., Ly, H. Q., McCabe, C. H., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome J Clin Hypertens (Greenwich). 2006;8(5):315-22. Abstract

Gibson, C. M., Karmpaliotis, D., Kosmidou, I., Murphy, S. A., Kirtane, A. J., Budiu, D., Ray, K. K., Herrmann, H. C., Lakkis, N., Kovach, R., French, W., Blankenship, J., Lui, H. H., Palabrica, T., Jennings, L. K., Cohen, D. J., Morrow, D. A. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome Am J Cardiol. 2006;97(10):1473-7.

Gibson, C. M., Kirtane, A. J., Murphy, S. A., Rohrbeck, S., Menon, V., Lins, J., Kazziha, S., Rokos, I., Shammas, N. W., Palabrica, T. M., Fish, P., McCabe, C. H., Braunwald, E. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial Am Heart J. 2006;152(4):668-75. Abstract

Gibson, C. M., Ly, H. Q., Murphy, S. A., Ciaglo, L. N., Southard, M. C., Stein, E. B., Buros, J. L., Sabatine, M. S., Cannon, C. P. Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28) Am J Cardiol. 2006;98(6):761-3.

Kirtane, A. J., Vafai, J. J., Murphy, S. A., Aroesty, J. M., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy Eur Heart J. 2006;27(17):2040-5.

Kugelmass, A. D., Sadanandan, S., Lakkis, N., Dibattiste, P. M., Robertson, D. H., Demopoulos, L. A., Gibson, C. M., Weintraub, W. S., Murphy, S. A., Cannon, C. P. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18 Crit Pathw Cardiol. 2006;5(3):167-72.

Ly, H. Q., Kirtane, A. J., Murphy, S. A., Buros, J., Cannon, C. P., Braunwald, E., Gibson, C. M. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials) Am J Cardiol. 2006;98(1):5-Jan. Abstract

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Skene, A., McCabe, C. H., Braunwald, E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial Am Heart J. 2006;151(6):1186 e1-9. Abstract

O'Donoghue, M., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial Circulation. 2006;113(14):1745-52.

O'Donoghue, M., de Lemos, J. A., Morrow, D. A., Murphy, S. A., Buros, J. L., Cannon, C. P., Sabatine, M. S. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes Circulation. 2006;114(6):550-7. Abstract

Pinto, D. S., Kirtane, A. J., Nallamothu, B. K., Murphy, S. A., Cohen, D. J., Laham, R. J., Cutlip, D. E., Bates, E. R., Frederick, P. D., Miller, D. P., Carrozza, J. P., Jr., Antman, E. M., Cannon, C. P., Gibson, C. M. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy Circulation. 2006;114(19):2019-25. Abstract

Ray, K. K., Morrow, D. A., Shui, A., Rifai, N., Cannon, C. P. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22) Am J Cardiol. 2006;98(7):861-5. Abstract

Sabatine, M. S., Morrow, D. A., McCabe, C. H., Antman, E. M., Gibson, C. M., Cannon, C. P. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction Am Heart J. 2006;151(1):25-31.

Scirica, B. M., Sabatine, M. S., Morrow, D. A., Gibson, C. M., Murphy, S. A., Wiviott, S. D., Giugliano, R. P., McCabe, C. H., Cannon, C. P., Braunwald, E. The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study J Am Coll Cardiol. 2006;48(1):37-42.

Wiviott, S. D., Antman, E. M., Gibson, C. M., Montalescot, G., Riesmeyer, J., Weerakkody, G., Winters, K. J., Warmke, J. W., McCabe, C. H., Braunwald, E. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J. 2006;152(4):627-35. Abstract

Wiviott, S. D., Cannon, C. P. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy Curr Opin Lipidol. 2006;17(6):626-30. Abstract

Wiviott, S. D., de Lemos, J. A., Cannon, C. P., Blazing, M., Murphy, S. A., McCabe, C. H., Califf, R., Braunwald, E. A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22 Circulation. 2006;113(11):1406-14. Abstract

de Lemos, J. A., Wiviott, S. D., Murphy, S. A., Blazing, M. A., Lewis, E. F., Califf, R. M., Pfeffer, M. A., Braunwald, E. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial Am J Cardiol. 2006;98(6):739-42.

Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., Antman, E. M. Diabetes and mortality following acute coronary syndromes JAMA. 2007;298(7):765-75. Abstract

Gibson, C. M., Buros, J., Ciaglo, L. N., Southard, M. C., Takao, S., Harrigan, C., Filopei, J., Lew, M., Marble, S. J., Murphy, S. A., Cohen, M. G. Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarction Am J Cardiol. 2007;100(1):13-7. Abstract

Gibson, C. M., Murphy, S. A., Montalescot, G., Morrow, D. A., Ardissino, D., Cohen, M., Gulba, D. C., Kracoff, O. H., Lewis, B. S., Roguin, N., Antman, E. M., Braunwald, E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol. 2007;49(23):2238-46.

Giraldez, R. R., Nicolau, J. C., Corbalan, R., Gurfinkel, E. P., Juarez, U., Lopez-Sendon, J., Parkhomenko, A., Molhoek, P., Mohanavelu, S., Morrow, D. A., Antman, E. M. Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis Eur Heart J. 2007;28(13):1566-73.

Giugliano, R. P., Wiviott, S. D., Stone, P. H., Simon, D. I., Schweiger, M. J., Bouchard, A., Leesar, M. A., Goulder, M. A., Deitcher, S. R., McCabe, C. H., Braunwald, E. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial J Am Coll Cardiol. 2007;49(25):2398-407. Abstract

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Resnic, F. S. Validating an automated outcomes surveillance application using data from a terminated randomized, controlled trial (OPUS [TIMI-16]) AMIA Annu Symp Proc. 2007;NA(NA):1043. Abstract

McLean, D. S., Sabatine, M. S., Guo, W., McCabe, C. H., Cannon, C. P. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28 J Thromb Thrombolysis. 2007;24(2):85-91.

Mega, J. L., Morrow, D. A., Ostor, E., Dorobantu, M., Qin, J., Antman, E. M., Braunwald, E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction Circulation. 2007;115(22):2822-2828. Abstract

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Murphy, S. A., Budaj, A., Varshavsky, S., Wolff, A. A., Skene, A., McCabe, C. H., Braunwald, E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA. 2007;297(16):1775-83. Abstract

Murphy, S. A., Gibson, C. M., Morrow, D. A., Van de Werf, F., Menown, I. B., Goodman, S. G., Mahaffey, K. W., Cohen, M., McCabe, C. H., Antman, E. M., Braunwald, E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis Eur Heart J. 2007;28(17):2077-86. Abstract

Omland, T., Sabatine, M. S., Jablonski, K. A., Rice, M. M., Hsia, J., Wergeland, R., Landaas, S., Rouleau, J. L., Domanski, M. J., Hall, C., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial J Am Coll Cardiol. 2007;50(3):205-14. Abstract

Ray, K. K., Cannon, C. P., Morrow, D. A., Kirtane, A. J., Buros, J., Rifai, N., McCabe, C. H., Gibson, C. M., Braunwald, E. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18 Eur Heart J. 2007;28(7):806-13. Abstract

Ruff, C. T., Wiviott, S. D., Morrow, D. A., Mohanavelu, S., Murphy, S. A., Antman, E. M., Braunwald, E. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction American Journal of Medicine. 2007;120(11):993-8. Abstract

Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M., Pfeffer, M. A., Braunwald, E., Peace Investigators Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease Circulation. 2007;115(12):1528-36. Abstract

Sabatine, M. S., Morrow, D. A., O'Donoghue, M., Jablonksi, K. A., Rice, M. M., Solomon, S., Rosenberg, Y., Domanski, M. J., Hsia, J. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease Arterioscler Thromb Vasc Biol. 2007;27(11):2463-9. Abstract

Scirica, B. M., Morrow, D. A., Sadowski, Z., Ruda, M., Nicolau, J. C., Giugliano, R. P., Wiviott, S. D., Sabatine, M. S., Shui, A., Antman, E. M., Braunwald, E. A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study Eur Heart J. 2007;28(17):2070-6.

Steinberg, B. A., Steg, P. G., Bhatt, D. L., Fonarow, G. C., Zeymer, U., Cannon, C. P. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry) Am J Cardiol. 2007;99(9):1212-5. Abstract

Verheugt, F. W., Montalescot, G., Sabatine, M. S., Soulat, L., Lambert, Y., Lapostolle, F., Adgey, J., Cannon, C. P. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial J Thromb Thrombolysis. 2007;23(3):173-9.

Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F. J., Ardissino, D., De Servi, S., Murphy, S. A., Riesmeyer, J., Weerakkody, G., Gibson, C. M., Antman, E. M. Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med. 2007;357(20):2001-15. Abstract

Yeh, R. W., Wiviott, S. D., Giugliano, R. P., Morrow, D. A., Shui, A., Qin, J., Scirica, B., Bradner, J. E., Jang, I. K., Gibson, C. M., Antman, E. M. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes Am J Cardiol. 2007;100(12):1734-8. Abstract

Ahmed, S., Cannon, C. P., Giugliano, R. P., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E., Gibson, C. M. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2008;131(1):105-12. Abstract

Antman, E. M., Wiviott, S. D., Murphy, S. A., Voitk, J., Hasin, Y., Widimsky, P., Chandna, H., Macias, W., McCabe, C. H., Braunwald, E. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis J Am Coll Cardiol. 2008;51(21):2028-33. Abstract

Brilakis, E. S., de Lemos, J. A., Cannon, C. P., Wiviott, S. D., Murphy, S. A., Morrow, D. A., Sabatine, M. S., Banerjee, S., Blazing, M. A., Califf, R. M., Braunwald, E. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol. 2008;102(5):552-8. Abstract

Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, Strony J, Musliner TA, McCabe CH, Veltri E, Braunwald E, Califf RM. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J. 2008;156:826-32. Abstract

Gibson, C. M., Murphy, S. A., Pride, Y. B., Kirtane, A. J., Aroesty, J. M., Stein, E. B., Ciaglo, L. N., Southard, M. C., Sabatine, M. S., Cannon, C. P., Braunwald, E. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study Am Heart J. 2008;155(1):133-9.

Gibson, C. M., Pride, Y. B., Buros, J. L., Kunadian, V., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Braunwald, E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy Am J Cardiol. 2008;101(9):1232-8.

Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E., Shui, A., Murphy, S. A., Pinto, D. S., Zimetbaum, P. J., Sabatine, M. S., Cannon, C. P., Josephson, M. E. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol. 2008;51(5):546-51.

Hsia, J., Jablonski, K. A., Rice, M. M., Sabatine, M. S., Zabalgoitia, M., Maggioni, A., Cuddy, T. E., Domanski, M. J., Geller, N. L., Flaker, G., Solomon, S., Omland, T., Rouleau, J. L., Peace Investigators Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function Am J Cardiol. 2008;101(4):457-61. Abstract

Iakoubova, O. A., Tong, C. H., Rowland, C. M., Kirchgessner, T. G., Young, B. A., Arellano, A. R., Shiffman, D., Sabatine, M. S., Campos, H., Packard, C. J., Pfeffer, M. A., White, T. J., Braunwald, E., Shepherd, J., Devlin, J. J., Sacks, F. M. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials J Am Coll Cardiol. 2008;51(4):435-43. Abstract

Mega, J. L., Morrow, D. A., de Lemos, J. A., Mohanavelu, S., Cannon, C. P., Sabatine, M. S. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2008;51(25):2422-9. Abstract

Miller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., Braunwald, E. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial J Am Coll Cardiol. 2008;51(7):724-30.

Morrow, D. A., Sabatine, M. S., Brennan, M. L., de Lemos, J. A., Murphy, S. A., Ruff, C. T., Rifai, N., Cannon, C. P., Hazen, S. L. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J. 2008;29(9):1096-102.

Morrow, D. A., Wang, Y., Croce, K., Sakuma, M., Sabatine, M. S., Gao, H., Pradhan, A. D., Healy, A. M., Buros, J., McCabe, C. H., Libby, P., Cannon, C. P., Braunwald, E., Simon, D. I. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial Am Heart J. 2008;155(1):49-55.

Murphy, S. A., Antman, E. M., Wiviott, S. D., Weerakkody, G., Morocutti, G., Huber, K., Lopez-Sendon, J., McCabe, C. H., Braunwald, E. Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial Eur Heart J. 2008;29(20):2473-9. Abstract

O'Donoghue, M., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Wallentin, L., Windhausen, F., Sabatine, M. S. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis JAMA. 2008;300(1):71-80. Abstract

O'Donoghue, M., Morrow, D. A., Cannon, C. P., Guo, W., Murphy, S. A., Gibson, C. M., Sabatine, M. S. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur Heart J. 2008;29(8):984-91.

Pinto, D. S., Kirtane, A. J., Pride, Y. B., Murphy, S. A., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study) Am J Cardiol. 2008;101(3):303-7.

Pride, Y. B., Buros, J. L., Lord, E., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days J Thromb Thrombolysis. 2008;26(2):106-12. Abstract

Sabatine, M. S., Hamdalla, H. N., Mehta, S. R., Fox, K. A., Topol, E. J., Steinhubl, S. R., Cannon, C. P. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Am Heart J. 2008;155(5):910-7.

Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., Lee, R. T. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation. 2008;117(15):1936-44.

Sabatine, M. S., Ploughman, L., Simonsen, K. L., Iakoubova, O. A., Kirchgessner, T. G., Ranade, K., Tsuchihashi, Z., Zerba, K. E., Long, D. U., Tong, C. H., Packard, C. J., Pfeffer, M. A., Devlin, J. J., Shepherd, J., Campos, H., Sacks, F. M., Braunwald, E. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy Arterioscler Thromb Vasc Biol. 2008;28(3):562-7. Abstract

Wiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., McCabe, C. H., Antman, E. M. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38 Circulation. 2008;118(16):1626-36. Abstract

Wiviott, S. D., Braunwald, E., McCabe, C. H., Horvath, I., Keltai, M., Herrman, J. P., Van de Werf, F., Downey, W. E., Scirica, B. M., Murphy, S. A., Antman, E. M. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet. 2008;371(9621):1353-63. Abstract

Arnold, S. V., Morrow, D. A., Lei, Y., Cohen, D. J., Mahoney, E. M., Braunwald, E., Chan, P. S. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial Circulation Cardiovascular quality and outcomes. 2009;2(4):344-53. Abstract

Berger, J. S., Bhatt, D. L., Cannon, C. P., Chen, Z., Jiang, L., Jones, J. B., Mehta, S. R., Sabatine, M. S., Steinhubl, S. R., Topol, E. J., Berger, P. B. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis J Am Coll Cardiol. 2009;54(21):1935-45. Abstract

Cannon, C. P., Dansky, H. M., Davidson, M., Gotto, A. M., Jr., Brinton, E. A., Gould, A. L., Stepanavage, M., Liu, S. X., Shah, S., Rubino, J., Gibbons, P., Hermanowski-Vosatka, A., Binkowitz, B., Mitchel, Y., Barter, P. Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib Am Heart J. 2009;158(4):513-519 e3. Abstract

Cheng, S., Morrow, D. A., Sloan, S., Antman, E. M., Sabatine, M. S. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction Circulation. 2009;119(9):1195-202.

Desai, N. R., Mega, J. L., Jiang, S., Cannon, C. P., Sabatine, M. S. Interaction between cigarette smoking and clinical benefit of clopidogrel Journal of the American College of Cardiology. 2009;53(15):1273-8. Abstract

Gibson, C. M., Mega, J. L., Jennings, L. K., Mohanavelu, S., Misselwitz, F., Plotnikov, A., Sun, X., Zolynas, R., Braunwald, E. Effect of Rivaroxaban on Markers of Coagulation in Patients With Acute Coronary Syndromes: An ATLAS ACS-TIMI 46 Substudy Circulation. 2009;120(18):S1035-S1035.

Gibson, C. M., Pride, Y. B., Aylward, P. E., Col, J. J., Goodman, S. G., Gulba, D., Bergovec, M., Kunadian, V., Zorkun, C., Buros, J. L., Murphy, S. A., Antman, E. M. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis J Thromb Thrombolysis. 2009;27(1):7-Nov.

Giraldez, R. R., Sabatine, M. S., Morrow, D. A., Mohanavelu, S., McCabe, C. H., Antman, E. M., Braunwald, E. Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction American heart journal. 2009;157(3):517-24. Abstract

Giraldez, R. R., Wiviott, S. D., Nicolau, J. C., Mohanavelu, S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis Drugs. 2009;69(11):1433-43. Abstract

Giugliano, R. P., White, J. A., Bode, C., Armstrong, P. W., Montalescot, G., Lewis, B. S., van 't Hof, A., Berdan, L. G., Lee, K. L., Strony, J. T., Hildemann, S., Veltri, E., Van de Werf, F., Braunwald, E., Harrington, R. A., Califf, R. M., Newby, L. K. Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med. 2009;360(21):2176-90. Abstract

Mega, J. L., Braunwald, E., Lee, M., Misselwitz, F., Mohanavelu, S., Notani, R., Peters, G., Gibson, C. M. Cessation of Rivaroxaban in Post-ACS Patients is Not Associated With Clinical Evidence of Rebound Hypercoagulability: An ATLAS ACS-TIMI 46 Substudy Circulation. 2009;120(18):S1002-S1002.

Mega, J. L., Braunwald, E., Mohanavelu, S., Burton, P., Poulter, R., Misselwitz, F., Hricak, V., Barnathan, E. S., Bordes, P., Witkowski, A., Markov, V., Oppenheimer, L., Gibson, C. M. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial Lancet. 2009;374(9683):29-38. Abstract

Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W. L., Braunwald, E., Sabatine, M. S. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes Circulation. 2009;119(19):2553-60. Abstract

Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Hockett, R. D., Brandt, J. T., Walker, J. R., Antman, E. M., Macias, W., Braunwald, E., Sabatine, M. S. Cytochrome p-450 polymorphisms and response to clopidogrel New England journal of medicine. 2009;360(4):354-62. Abstract

Michelson, A. D., Frelinger, A. L., 3rd, Braunwald, E., Downey, W. E., Angiolillo, D. J., Xenopoulos, N. P., Jakubowski, J. A., Li, Y., Murphy, S. A., Qin, J., McCabe, C. H., Antman, E. M., Wiviott, S. D. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial European heart journal. 2009;30(14):1753-63. Abstract

Montalescot, G., Wiviott, S. D., Braunwald, E., Murphy, S. A., Gibson, C. M., McCabe, C. H., Antman, E. M. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet. 2009;373(9665):723-31. Abstract

Morrow, D. A., Wiviott, S. D., White, H. D., Nicolau, J. C., Bramucci, E., Murphy, S. A., Bonaca, M. P., Ruff, C. T., Scirica, B. M., McCabe, C. H., Antman, E. M., Braunwald, E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction Circulation. 2009;119(21):2758-64. Abstract

Murphy, S. A., Cannon, C. P., Wiviott, S. D., McCabe, C. H., Braunwald, E. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial Journal of the American College of Cardiology. 2009;54(25):2358-62. Abstract

O'Donoghue, M., Antman, E. M., Braunwald, E., Murphy, S. A., Steg, P. G., Finkelstein, A., Penny, W. F., Fridrich, V., McCabe, C. H., Sabatine, M. S., Wiviott, S. D. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis Journal of the American College of Cardiology. 2009;54(8):678-85. Abstract

Olenchock, B. A., Fonarow, G. G., Pan, W., Hernandez, A., Cannon, C. P. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes Am J Cardiol. 2009;103(3):295-300. Abstract

Omland, T., de Lemos, J. A., Sabatine, M. S., Christophi, C. A., Rice, M. M., Jablonski, K. A., Tjora, S., Domanski, M. J., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., Braunwald, E., Prevention of Events with Angiotensin Converting Enzyme Inhibition Trial, Investigators A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med. 2009;361(26):2538-47. Abstract

Pride, Y. B., Wiviott, S. D., Buros, J. L., Zorkun, C., Tariq, M. U., Antman, E. M., Braunwald, E., Gibson, C. M. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy American heart journal. 2009;158(3):e21-6. Abstract

Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Ridker, P. M., Braunwald, E. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22 Arteriosclerosis, thrombosis, and vascular biology. 2009;29(3):424-30. Abstract

Sabatine, M. S., Antman, E. M., Widimsky, P., Ebrahim, I. O., Kiss, R. G., Saaiman, A., Polasek, R., Contant, C. F., McCabe, C. H., Braunwald, E. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial Lancet. 2009;374(9692):787-95. Abstract

Scirica, B. M., Morrow, D. A., Budaj, A., Dalby, A. J., Mohanavelu, S., Qin, J., Aroesty, J., Hedgepeth, C. M., Stone, P. H., Braunwald, E. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2009;53(16):1411-21. Abstract

Thomas, D., Giugliano, R. P. ExTRACT-TIMI 25 in perspective: key lessons regarding enoxaparin as an adjunct to fibrinolytic therapy J Thromb Thrombolysis. 2009;27(1):10-Jan. Abstract

Truong, Q. A., Cannon, C. P., Zakai, N. A., Rogers, I. S., Giugliano, R. P., Wiviott, S. D., McCabe, C. H., Morrow, D. A., Braunwald, E. Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial Am Heart J. 2009;157(4):673-9 e1. Abstract

Wilson, S. R., Sabatine, M. S., Braunwald, E., Sloan, S., Murphy, S. A., Morrow, D. A. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial American heart journal. 2009;158(3):386-91. Abstract

Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., Morrow, D. A. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial Journal of the American College of Cardiology. 2009;53(17):1510-6. Abstract

Bangalore, S., Qin, J., Sloan, S., Murphy, S. A., Cannon, C. P. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation. 2010;122(21):2142-51. Abstract

Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., Scirica, B. M., Murphy, S. A., Cannon, C. P., Cogent Investigators Clopidogrel with or without omeprazole in coronary artery disease N Engl J Med. 2010;363(20):1909-17. Abstract

Bonaca, M., Scirica, B., Sabatine, M., Dalby, A., Spinar, J., Murphy, S. A., Jarolim, P., Braunwald, E., Morrow, D. A. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I J Am Coll Cardiol. 2010;55(19):2118-24. Abstract

Bonaca, Marc P., Scirica, Bejamin M., Sabatine, Marc S., Jarolim, Petr, Murphy, Sabina A., Chamberlin, Janna S., Rhodes, Daniel W., Southwick, Paula C., Braunwald, Eugene, Morrow, David A. Metalloproteinase PAPP-A and Outcomes in Patients with ACS: Observations from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet. 2010;375:283-93. Abstract

Cannon, C. P., Shah, S., Dansky, H. M., Davidson, M., Brinton, E. A., Gotto, A. M., Stepanavage, M., Liu, S. X., Gibbons, P., Ashraf, T. B., Zafarino, J., Mitchel, Y., Barter, P. Safety of anacetrapib in patients with or at high risk for coronary heart disease N Engl J Med. 2010;363(25):2406-15. Abstract

Forman, D. E., Chen, A. Y., Wiviott, S. D., Wang, T. Y., Magid, D. J., Alexander, K. P. Comparison of outcomes in patients aged <75, 75 to 84, and ≥ 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG) Am J Cardiol. 2010;106(10):1382-8. Abstract

Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Cannon, C. P., Saucedo, J. F., Kontos, M. C., Wiviott, S. D., Acute Coronary, Treatment, Intervention Outcomes Network, registry Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry Circulation. 2010;121(3):357-65. Abstract

Harkness, J. R., Sabatine, M. S., Braunwald, E., Morrow, D. A., Sloan, S., Wiviott, S. D., Giugliano, R. P., Antman, E. M., Cannon, C. P., Scirica, B. M. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction Am Heart J. 2010;159(1):55-62. Abstract

James S, Angiolillo DJ, Cornel JH, Erlinge D, Husted S, Kontny F, Maya J, Nicolau JC, Spinar J, Storey RF, Stevens SR, Wallentin L; PLATO Study Group. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Euro Heart J. 2010;31:3006-3016. Abstract

Khera, A. V., Wolfe, M. L., Cannon, C. P., Qin, J., Rader, D. J. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study) Am J Cardiol. 2010;106(4):451-6. Abstract

Kontos, M. C., de Lemos, J. A., Ou, F. S., Wiviott, S. D., Foody, J. M., Newby, L. K., Chen, A., Roe, M. T. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry Am Heart J. 2010;160(5):819-25. Abstract

Maree, A. O., Vangjeli, C., Jneid, H., Ryan, J., Cox, D., Cannon, C. P., Shields, D. C., Fitzgerald, D. J. G-protein beta3 subunit polymorphism and bleeding in the orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16 trial J Thromb Haemost. 2010;8(5):934-41. Abstract

Mauri, L., Kereiakes, D. J., Normand, S. L., Wiviott, S. D., Cohen, D. J., Holmes, D. R., Bangalore, S., Cutlip, D. E., Pencina, M., Massaro, J. M. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J. 2010;160(6):1035-41, 1041 e1. Abstract

Mega, J. L., Close, S. L., Wiviott, S. D., Shen, L., Walker, J. R., Simon, T., Antman, E. M., Braunwald, E., Sabatine, M. S. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis Lancet. 2010;376(9749):1312-9. Abstract

Mega, J. L., Hochman, J. S., Scirica, B. M., Murphy, S. A., Sloan, S., McCabe, C. H., Merlini, P., Morrow, D. A. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Circulation. 2010;121(16):1809-17. Abstract

Mega, J. L., Simon, T., Collet, J. P., Anderson, J. L., Antman, E. M., Bliden, K., Cannon, C. P., Danchin, N., Giusti, B., Gurbel, P., Horne, B. D., Hulot, J. S., Kastrati, A., Montalescot, G., Neumann, F. J., Shen, L., Sibbing, D., Steg, P. G., Trenk, D., Wiviott, S. D., Sabatine, M. S. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JAMA. 2010;304(16):1821-30. Abstract

Melloni, Chiara, James, Stefan K., White, Jennifer A., Giugliano, Robert P., Harrington, Robert A., Huber, Kurt, Armstrong, Paul W., Califf, Robert M., Van de Werf, Frans, Montalescot, Gilles, Newby, L. Kristin Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients with Acute Coronary Syndromes and Reduced Renal Function J Am Coll Cardiol. 2010;55(10s1):A102.E957-A102.E957.

Morrow, D. A., Antman, E. M., Fox, K. A., White, H. D., Giugliano, R., Murphy, S. A., McCabe, C. H., Braunwald, E. One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial European heart journal. 2010;31(17):2097-102. Abstract

Morrow, D. A., Scirica, B. M., Sabatine, M. S., de Lemos, J. A., Murphy, S. A., Jarolim, P., Theroux, P., Bode, C., Braunwald, E. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2010;55(12):1189-96. Abstract

Pride, Y. B., Tung, P., Mohanavelu, S., Zorkun, C., Wiviott, S. D., Antman, E. M., Giugliano, R., Braunwald, E., Gibson, C. M. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy JACC Cardiovascular interventions. 2010;3(8):806-11. Abstract

Sherwood, M. W., Morrow, D. A., Scirica, B. M., Jiang, S. T., Bode, C., Rifai, N., Gerszten, R. E., Gibson, C. M., Cannon, C. P., Braunwald, E., Sabatine, M. S. Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: Analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY) - Thrombolysis in Myocardial Infarction (TIMI) 28 American Heart Journal. 2010;159(6):964-U3. Abstract

Shiffman, D., Sabatine, M. S., Louie, J. Z., Kirchgessner, T. G., Iakoubova, O. A., Campos, H., Devlin, J. J., Sacks, F. M. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial Am J Cardiol. 2010;105(9):1300-5. Abstract

Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group. Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis. Circulation. 2010;122:2131-2141. Abstract

Syed, Zeeshan, Scirica, Benjamin M., Mohanavelu, Satishkumar, Morrow, David A., Stultz, Collin M., Guttag, John Association of Heart Rate Turbulence, Deceleration Capacity and Morphologic Variability with Sudden Cardiac Death Following Non-ST-Elevation Acute Coronary Syndrome: Results from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Tanguay, Jean-François, Newby, L. Kristin, Hochman, Judith, Westerhout, Cynthia M., Califf, Robert M., Gibson, C. Michael, Giugliano, Robert P., Harrington, Robert A., Van de Werf, Frans, Armstrong, Paul W. SEX DIFFERENCES IN HIGH-RISK ACUTE CORONARY SYNDROMES: INSIGHTS FROM EARLY-ACS J Am Coll Cardiol. 2010;55(10s1):A120.E1122-A120.E1122.

Wang, Tracy, White, Jennifer A., Giugliano, Robert P., Tricoci, Pierluigi, Harrington, Robert A., Montalescot, Gilles, Zeymer, Uwe, Van de Werf, Frans, Armstrong, Paul W., Braunwald, Eugene, Califf, Robert M., Newby, L. Kristin UPFRONT CLOPIDOGREL USE AND THE EFFICACY AND SAFETY OF EARLY EPTIFIBATIDE USE IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN ANALYSIS FROM THE EARLY VERSUS DELAYED PROVISIONAL EPTIFIBATIDE IN ACUTE CORONARY SYNDROMES (EARLY ACS) TRIAL Journal of the American College of Cardiology. 2010;55(10, Supplement):A47.E451.

Wilson, Sean R., Wiviott, Stephen D., Antman, Elliott M., Giugliano, Robert P., Murphy, Sabina A., Sloan, Sarah, Braunwald, Eugene, Morrow, David A. APPLICATION OF THE TIMI RISK SCORE, A SIMPLE BEDSIDE TOOL, FOR TIMING OF DISCHARGE AFTER FIBRINOLYSIS OR PRIMARY ANGIOPLASTY FOR ST-ELEVATION MI IN THE EXTRACT-TIMI 25 AND TRITON-TIMI 38 TRIALS Journal of the American College of Cardiology. 2010;55(10, Supplement):A125.E1173.

Abtahian, F., Olenchock, B., Ou, F. S., Kontos, M. C., Saucedo, J. F., Scirica, B. M., Desai, N., Peterson, E., Roe, M., Cannon, C. P., Wiviott, S. D. Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry) Am J Cardiol. 2011;107(10):1441-6. Abstract

Ahmed, S., Michael Gibson, C., Cannon, C. P., Murphy, S. A., Sabatine, M. S. Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysis J Thromb Thrombolysis. 2011;31(4):493-500. Abstract

Bonaca, M. P., Morrow, D. A., Braunwald, E., Cannon, C. P., Jiang, S., Breher, S., Sabatine, M. S., Kempf, T., Wallentin, L., Wollert, K. C. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 Arteriosclerosis, thrombosis, and vascular biology. 2011;31(1):203-10. Abstract

Bonaca, M. P., Ruff, C. T., Grandin, E. W., Murphy, S. A., Jarolim, P., Conrad, M. J., Vora, A., Sabatine, M. S., Braunwald, E., Morrow, D. A. Evaluation of the Diagnostic Performance of an Investigational Ultra-Sensitive Assay for CARDIAC TROPONIN I Journal of the American College of Cardiology. 2011;57(14):E1018-E1018.

Bonaca, Marc P., Braunwald, Eugene, Murphy, Sabina A., Miller, Debra, Herrman, Jp R., Gottlieb, Shmuel, Menozzi, Alberto, McCabe, Carolyn H., Antman, Elliot M., Wiviott, Stephen W. LONG-TERM THIENOPYRIDINE THERAPY AND OUTCOMES IN PATIENTS WITH ACS TREATED WITH CORONARY STENTING: THE PRIMARY RESULTS OF THE TIMI-38 CORONARY STENT REGISTRY Journal of the American College of Cardiology. 2011;57(14, Supplement):E906.

Braunwald, E. Clinical efforts to reduce myocardial infarct size--the next step J Cardiovasc Pharmacol Ther. 2011;16(4-Mar):349-53. Abstract

Britton, K. A., Aggarwal, V., Chen, A. Y., Alexander, K. P., Amsterdam, E., Fraulo, E., Muntner, P., Thomas, L., McGuire, D. K., Wiviott, S. D., Roe, M. T., Schubart, U. K., Fox, C. S. No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction Am Heart J. 2011;161(4):657-663 e1. Abstract

Desai, N. R., Morrow, D. A., Murphy, S. A., Gerszten, R. E., Cannon, C. P., Sabatine, M. S. Evaluation of Multiple Biomarkers of Cardiomyocyte Stress or Injury to Predict Cardiovascular Death or CHF in STEMI: Findings from CLARITY-TIMI 28 Circulation. 2011;124(21):NA.

Frelinger, A. L., 3rd, Michelson, A. D., Wiviott, S. D., Trenk, D., Neumann, F. J., Miller, D. L., Jakubowski, J. A., Costigan, T. M., McCabe, C. H., Antman, E. M., Braunwald, E. Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44 Thrombosis and haemostasis. 2011;106(2):219-26. Abstract

Gibson, C. M., Mega, J. L., Burton, P., Goto, S., Verheugt, F., Bode, C., Plotnikov, A., Sun, X., Cook-Bruns, N., Braunwald, E. Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome American heart journal. 2011;161(5):815-821 e6. Abstract

Harkness, J. R., Morrow, D. A., Braunwald, E., Ren, F., Lopez-Sendon, J., Bode, C., Budaj, A., Scirica, B. M. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial) American journal of cardiology. 2011;108(10):1373-81. Abstract

James SK, Roe MT, Cannon CP, Cornel JH, Horrow J, Husted S, Katus H, Morais J, Steg PG, Storey RF, Stevens S, Wallentin L, Harrington RA; PLATO Study Group. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. Brit Med J. 2011;342:d3527. Abstract

Kadakia, M. B., Fox, C. S., Scirica, B. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Heart. 2011;97(21):1782-7. Abstract

Kunadian, V., Pride, Y. B., Buros, J. L., Ciaglo, L. N., Morrow, D. A., Gibson, C. M. Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: a PROTECT TIMI-30 analysis J Thromb Thrombolysis. 2011;32(4):448-52. Abstract

Kunadian, V., Zorkun, C., James, S., Wu, J. H., Muhammad, A., Storey, R., Steg, P. G., Katus, H., Emanuelsson, H., Horrow, J., Maya, J., Wallentin, L., Harrington, R., Gibson, C. M. ANGIOGRAPHIC OUTCOMES IN THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL Journal of the American College of Cardiology. 2011;57(14):E946-E946.

Li, Y., Sabatine, M. S., Tong, C. H., Ford, I., Kirchgessner, T. G., Packard, C. J., Robertson, M., Rowland, C. M., Bare, L. A., Shepherd, J., Devlin, J. J., Iakoubova, O. A. Genetic variants in the KIF6 region and coronary event reduction from statin therapy Hum Genet. 2011;129(1):17-23. Abstract

Mega JL, Hochholzer W, Frelinger AL 3rd, Kluk MJ, Angiolillo DJ, Kereiakes DJ, Isserman S, Rogers WJ, Ruff CT, Contant C, Pencina MJ, Scirica BM, Longtine JA, Michelson AD, Sabatine MS. Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. J Am Med Assoc. 2011;306:2221-8. Abstract

Mega, Jessica L, Close, Sandra L, Wiviott, Stephen D, Man, Michael, Duvvuru, Suman, Walker, Joseph, Sundseth, Scott S, Macias, William L, Antman, Elliott M, Braunwald, Eugene, Sabatine, Marc S Abstract 11255: PON1 Q192R (rs662) Genetic Variant and Response to Clopidogrel and Prasugrel Circulation. 2011;124(21 Supplement):A11255.

Melloni, C., James, S. K., White, J. A., Giugliano, R. P., Harrington, R. A., Huber, K., Tricoci, P., Armstrong, P. W., Van de Werf, F., Montalescot, G., Califf, R. M., Newby, L. K., Early ACS Investigators Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function. Am Heart J. 2011;162(5):884-892. Abstract

Melloni, C., Roe, M. T., Chen, A. Y., Wang, T. Y., Wiviott, S. D., Ho, P. M., Peterson, E. D., Alexander, K. P. Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarction Circ Cardiovasc Qual Outcomes. 2011;4(6):603-9. Abstract

O'Donoghue ML, Braunwald E, White HD, Serruys P, Steg PG, Hochman J, Maggioni AP, Bode C, Weaver D, Johnson JL, Cicconetti G, Lukas MA, Tarka E, Cannon CP. Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. Am Heart J. 2011;162:613-619. Abstract

O'Donoghue, M. L., Bhatt, D. L., Wiviott, S. D., Goodman, S. G., Fitzgerald, D. J., Angiolillo, D. J., Goto, S., Montalescot, G., Zeymer, U., Aylward, P. E., Guetta, V., Dudek, D., Ziecina, R., Contant, C. F., Flather, M. D., Lancelot-Acs Investigators Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin-Acute Coronary Syndromes Trial Circulation. 2011;123(17):1843-53. Abstract

Ruff, C. T., Morrow, D. A., Jarolim, P., Ren, F., Contant, C. F., Kaur, A., Curtis, S. P., Laine, L., Cannon, C. P., Brune, K. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs J Rheumatol. 2011;38(6):1071-8. Abstract

Ruff, Christian T., Goodman, Shaun, Hod, Hanoch, Bode, Christoph, Widimsky, Petr, Kiss, Robert G., Contant, Charles F., Crugnale, Sharon E., Moryusef, Angele, Steg, Gabriel, Antman, Elliott M., Sabatine, Marc S. Evaluation of the Efficacy and Safety of Otamixaban vs. Unfractionated Heparin+Eptifibatide in Elderly Patients with Non-St-Elevation Acute Coronary Syndromes in the SEPIA ACS-TIMI 42 Trial Journal of the American College of Cardiology. 2011;57(14, Supplement):E915.

Scirica BM, Cannon CP, Emanuelsson H, Michelson EL, Harrington RA, Husted S, James S, Katus H, Pais P, Raev D, Spinar J, Steg PG, Storey RF, Wallentin L; PLATO Investigators. The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy. J Am Coll Cardiol. 2011;57:1908-16. Abstract

Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Price, D. L., Chen, R., Udell, J., Raz, I. The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study American heart journal. 2011;162(5):818-825 e6. Abstract

Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., de Lemos, J. L., Braunwald, E., Morrow, D. A. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial European heart journal. 2011;32(6):697-705. Abstract

Toleva O, Westerhout CM, Senaratne M, Bode C, Lindroos M, Ardissino D, Sulimov VA, Montalescot G, Newby LK, Giugliano RP, Van de Werf F, Armstrong PW Association of Hub and Spoke Practice Patterns with Coronary Interventino and Outcomes in Non ST Elevation Acute Coronary Syndromes (NSTE ACS): Insights from the Early Glycoprotein IIb/IIIa Inhibition in NSTE ACS (EARLY-ACS) Trial J Am Coll Cardiol. 2011;57(14):74.

Truong, Q. A., Murphy, S. A., McCabe, C. H., Armani, A., Cannon, C. P. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22 Circ Cardiovasc Qual Outcomes. 2011;4(3):328-36. Abstract

Udell, J. A., Morrow, D. A., Contant, C. F., Brunel, P. C., Prescott, M. F., Braunwald, E., Scirica, B. M., Avant Garde-Timi Investigators Inhibition of Renin-Angiotensin System (RAS) Reduces the Rise in Plasma Aldosterone Levels After Acute Coronary Syndromes in Patients with Preserved Left Ventricular Function: Insight From AVANT GARDE-TIMI 43 Trial Circulation. 2011;124(21):NA.

Waks, J. W., Sabatine, M. S., Cannon, C. P., Morrow, D. A., Gibson, C. M., Wiviott, S. D., Giugliano, R. P., Sloan, S., Braunwald, E., Scirica, B. M. Improved Risk Stratification in Patients with ST-Elevation Myocardial Infarction Treated with Fibrinolysis by Combining New Q-Waves on the Initial Electrocardiogram with ST-Segment Resolution-Observations from the CLARITY-TIMI 28 Trial Circulation. 2011;124(21):NA.

Wilson, S. R., Sabatine, M. S., Wiviott, S. D., Ray, K. K., De Lemos, J. A., Zhou, S., Rifai, N., Cannon, C. P., Morrow, D. A., Timi Study Group Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Am Heart J. 2011;161(6):1147-55 e1. Abstract

Wiviott, S. D., Desai, N., Murphy, S. A., Musumeci, G., Ragosta, M., Antman, E. M., Braunwald, E. Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies Am J Cardiol. 2011;108(7):905-11. Abstract

Wiviott, S. D., Flather, M. D., O'Donoghue, M. L., Goto, S., Fitzgerald, D. J., Cura, F., Aylward, P., Guetta, V., Dudek, D., Contant, C. F., Angiolillo, D. J., Bhatt, D. L., Lancelot-Cad Investigators Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin-Coronary Artery Disease Trial Circulation. 2011;123(17):1854-63. Abstract

Bonaca, M. P., Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., Chamberlin, J. S., Rhodes, D. W., Southwick, P. C., Braunwald, E., Morrow, D. A. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2012;60(4):332-8. Abstract

Bonaca, M. P., Wiviott, S. D., Braunwald, E., Murphy, S. A., Ruff, C. T., Antman, E. M., Morrow, D. A. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Circulation. 2012;125(4):577-83. Abstract

Braunwald, E. Unstable angina and non-ST elevation myocardial infarction Am J Respir Crit Care Med. 2012;185(9):924-32. Abstract

Bui, A. H., Bonaca, M. P., Sabatine, M. S., Ray, K. K., Rifai, N., Cannon, C. P., Morrow, D. A. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial J Thromb Thrombolysis. 2012;34(2):222-8. Abstract

Chin, C. T., Wang, T. Y., Li, S., Wiviott, S. D., deLemos, J. A., Kontos, M. C., Peterson, E. D., Roe, M. T. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines Clin Cardiol. 2012;35(7):424-9. Abstract

Hoffmann, U., Truong, Q. A., Fleg, J. L., Goehler, A., Gazelle, S., Wiviott, S., Lee, H., Udelson, J. E., Schoenfeld, D., Romicat,, II Design of the Rule Out Myocardial Ischemia/Infarction Using Computer Assisted Tomography: a multicenter randomized comparative effectiveness trial of cardiac computed tomography versus alternative triage strategies in patients with acute chest pain in the emergency department Am Heart J. 2012;163(3):330-8, 338 e1. Abstract

Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L; PLATO study group. Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes A Substudy From the Prospective Randomized PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circ Cardiovasc Qual Outcomes. 2012;5:680-688. Abstract

James SK, Storey RF, Khurmi NS, Husted S, Keltai M, Mahaffey KW, Maya J, Morais J, Lopes RD, Nicolau JC, Pais P, Raev D, Lopez-Sendon JL, Stevens SR, Becker RC; PLATO Study Group. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack. Circulation. 2012;125:2914-2921. Abstract

Kohli, P., Cannon, C. P. Triglycerides: how much credit do they deserve? Med Clin North Am. 2012;96(1):39-55. Abstract

Kumbhani, Dharam J., Bavry, Anthony A., Bhatt, Deepak L. Abstract 17864: Role of Aspiration and Mechanical Thrombectomy in Patients with Acute Myocardial Infarction Undergoing Primary Angioplasty: An Updated Meta-Analysis of Randomized Trials Circulation. 2012;126(21 Supplement):A17864.

Kumbhani, Dharam J., Fonarow, Gregg C., Cannon, Christopher P., Hernandez, Adrian F., Peterson, Eric D., Peacock, W. F., Laskey, Warren K., Grau-Sepulveda, Maria, Schwamm, Lee H., Bhatt, Deepak L. Abstract 17901: A Comparison of Temporal Trends in In-hospital Adherence to Secondary Prevention Measures Among Patients Undergoing Coronary Artery Bypass Graft Surgery, Percutaneous Coronary Intervention or No Intervention: Insights From the GWTG-CAD Circulation. 2012;126(21 Supplement):A17901.

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial International journal of cardiology. 2012;NA(NA):NA. Abstract

Maddox, T. M., Ho, P. M., Tsai, T. T., Wang, T. Y., Li, S., Peng, S. A., Wiviott, S. D., Masoudi, F. A., Rumsfeld, J. S. Clopidogrel use and hospital quality in medically managed patients with non-ST-segment-elevation myocardial infarction Circ Cardiovasc Qual Outcomes. 2012;5(4):523-31. Abstract

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366:9-19. Abstract

Mega, Jessica L, Braunwald, Eugene, Wiviott, Stephen D, Murphy, Sabina, Plotnikov, Alexei, Gotcheva, Nina, Ruda, Mikhail, Gibson, C. Michael Abstract 16014: Evaluation of Cardiac Events in ATLAS ACS 2-TIMI 51 Circulation. 2012;126(21 Supplement):A16014.

Mogabgab, O., Giugliano, R. P., Sabatine, M. S., Cannon, C. P., Mohanavelu, S., Wiviott, S. D., Antman, E. M., Braunwald, E. Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction Chronobiology International. 2012;29(10):1390-1396. Abstract

O'Malley, Ryan G, Morrow, David A, Bonaca, Marc P, Jarolim, Petr, Scirica, Benjamin M, Murphy, Sabina A, Conrad, Michael J, Cannon, Christopher P, Braunwald, Eugene, Sabatine, Marc S Abstract 11559: Determination of Cardiac Troponin with a Single-Molecule High-Sensitivity Assay and Outcomes in Patients with Stable Coronary Artery Disease: Analysis from PROVE IT-TIMI 22 Circulation. 2012;126(21 Supplement):A11559.

O'Malley, Ryan G., Bonaca, Marc, Sabatine, Marc, Scirica, Benjamin, Jarolim, Petr, Conrad, Michael, Murphy, Sabina, Braunwald, Eugene, Morrow, David PROGNOSTIC PERFORMANCE OF A SINGLE-MOLECULE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAY AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN-TIMI 36 Journal of the American College of Cardiology. 2012;59(13):E402-E402.

Rasoul S, van't Hof A, Clare R, Atar D, James S, Tanguay J, Betriu A, Brogan G, Giugliano R, Newby LK Routine Early Eptifibatide, Infarct Size and Outcomes in Non-ST segment Elevation Acute Coronary Syndrome Patients with Elevated Troponins on Admission J Am Coll Cardiol. 2012;59(13):A121.

Roe, M. T., Armstrong, P. W., Fox, K. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., Ardissino, D., Nicolau, J. C., Boden, W. E., Gurbel, P. A., Ruzyllo, W., Dalby, A. J., McGuire, D. K., Leiva-Pons, J. L., Parkhomenko, A., Gottlieb, S., Topacio, G. O., Hamm, C., Pavlides, G., Goudev, A. R., Oto, A., Tseng, C. D., Merkely, B., Gasparovic, V., Corbalan, R., Cinteza, M., McLendon, R. C., Winters, K. J., Brown, E. B., Lokhnygina, Y., Aylward, P. E., Huber, K., Hochman, J. S., Ohman, E. M., Trilogy Acs Investigators Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med. 2012;367(14):1297-309. Abstract

Roysland, R., Bonaca, M. P., Omland, T., Sabatine, M., Murphy, S. A., Scirica, B. M., Bjerre, M., Flyvbjerg, A., Braunwald, E., Morrow, D. A. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes Heart. 2012;98(10):786-91. Abstract

Ruff, C. T., Giugliano, R. P., Antman, E. M., Murphy, S. A., Lotan, C., Heuer, H., Merkely, B., Baracioli, L., Schersten, F., Seabro-Gomes, R., Braunwald, E., Wiviott, S. D. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world Int J Cardiol. 2012;155(3):424-9. Abstract

Sarma, Amy, Wiviott, Stephen D, Antman, Elliott, Mega, Jessica L, Murphy, Sabina A, Hoffman, Elaine, Sabatine, Marc S, O'Donoghue, Michelle L Abstract 17455: Pharmacodynamic Response to Clopidogrel in Men versus Women: Insights from the PRINCIPLE-TIMI 44 Trial Circulation. 2012;126(21 Supplement):A17455.

Scirica, Benjamin M, Bonaca, Marc P, Braunwald, Eugene, Betriu, Amadeo, Moliterno, David J, Corbalan, Ramon, Murphy, Sabina A, Morrow, David A Abstract 14508: Vorapaxar for Secondary Prevention after Myocardial Infarction According to Aspirin Dose - Insights from the TRA2{degrees}P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A14508.

Scirica, Benjamin M, Bonaca, Marc P, Braunwald, Eugene, Diehm, Curt H, Hankey, Graeme J, Moliterno, David J, Murphy, Sabina A, Morrow, David A Abstract 14419: Natural History of Atherothrombotic Events According to the Primary Diseased Vascular Bed - Insights from the TRA2P-TIMI 50 Trial Circulation. 2012;126(21 Supplement):A14419.

Steen, Dylan L, Cannon, Christopher P, Lele, Suhas, Rajapurkar, Mohan, Mukhopadhyay, Banibrata, Scirica, Benjamin M, Morrow, David A Abstract 18754: Prognostic Evaluation of Catalytic Iron in Patients with Acute Coronary Syndromes: Observations from OPUS-TIMI 16 Circulation. 2012;126(21 Supplement):A18754.

Steg, P. G., Mehta, S. R., Pollack, C. V., Jr., Bode, C., Gaudin, C., Fanouillere, K., Moryusef, A., Wiviott, S. D., Sabatine, M. S. Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy Am Heart J. 2012;164(6):817-24 e13. Abstract

Truong, Quynh A., Hayden, Douglas, Woodard, Pamela K., Kirby, Ruth, Chou, Eric T., Wiviott, Stephen D., Fleg, Jerome L., Schoenfeld, David A., Udelson, James E., Hoffmann, Udo Abstract 12596: Women Benefit Most from Early CCTA Compared to Standard ED Evaluation for Acute Chest Pain: The ROMICAT II Trial Circulation. 2012;126(21 Supplement):A12596.

Udell, J. A., Scirica, B. M., Braunwald, E., Raz, I., Steg, P. G., Davidson, J., Hirshberg, B., Bhatt, D. L. Statin and aspirin therapy for the prevention of cardiovascular events in patients with type 2 diabetes mellitus Clin Cardiol. 2012;35(12):722-9. Abstract

Udell, J. A., Steg, P. G., Scirica, B. M., Smith, S. C., Jr., Ohman, E. M., Eagle, K. A., Goto, S., Cho, J. I., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis Arch Intern Med. 2012;172(14):1086-95. Abstract

Udell, Jacob A, Bonaca, Marc P, Braunwald, Eugene, Hoffman, Elain P, Mohanavelu, Satishkumar, Jarolim, Petr, Michael, Conrad J, Desai, Nihar R, Sabatine, Marc S, Morrow, David A, Scirica, Benjamin M Abstract 11434: Low Level Elevation of Highly-Sensitive Cardiac Troponin I after Non-ST Elevation Acute Coronary Syndrome and Early Risk of Cardiac Ischemia and Ventricular Tachycardia: Analysis from MERLIN-TIMI 36 Circulation. 2012;126(21 Supplement):A11434.

Udell, Jacob A, O'Donoghue, Michelle L, Braunwald, Eugene, Scirica, Benjamin M, Wiviott, Stephen D, Bansilal, Sameer, Hoffman, Elaine B, Sabatine, Marc S, Cannon, Christopher P Abstract 15090: Evaluation of Right Bundle Branch Block for Risk Prediction and Guiding Revascularization Strategy in Patients with Non-ST-Elevation Acute Coronary Syndrome in the TACTICS-TIMI 18 Trial Circulation. 2012;126(21 Supplement):A15090.

Vavalle, J. P., Lopes, R. D., Chen, A. Y., Newby, L. K., Wang, T. Y., Shah, B. R., Ho, P. M., Wiviott, S. D., Peterson, E. D., Roe, M. T., Granger, C. B. Hospital length of stay in patients with non-ST-segment elevation myocardial infarction Am J Med. 2012;125(11):1085-94. Abstract

Zeymer, Uwe, Clare, Robert, Schweiger, Marc, van't Hof, Arnoud, Hochman, Judith, James, Stefan, White, Harvey, Widimsky, Petr, Betriu, Amadeo, Bode, Christoph, Califf, Robert, Harrington, Robert, Giugliano, Robert, Gibson, C. Michael, Newby, L. Kristin FREQUENCY, CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS, AND OUTCOMES OF HIGH-RISK NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES PATIENTS WITH LEFT CIRCUMFLEX CULPRIT LESIONS Journal of the American College of Cardiology. 2012;59(13, Supplement):E405.

Amin, S. T., Morrow, D. A., Braunwald, E., Sloan, S., Contant, C., Murphy, S., Antman, E. M. Dynamic TIMI Risk Score for STEMI J Am Heart Assoc. 2013;2(1):e003269. Abstract

Bagai, A., White, J. A., Lokhnygina, Y., Giugliano, R. P., Van de Werf, F., Montalescot, G., Armstrong, P. W., Tricoci, P., Gibson, C. M., Califf, R. M., Harrington, R. A., Newby, L. K. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial Am Heart J. 2013;166(3):466-473 e1. Abstract

Bansilal, S., Wiviott, S., Becker, R., Harrington, R., Himmelmann, A., Neely, B., Husted, S., Storey, R., Steg, P., Katus, H., James, S., Wallentin, L., Cannon, C., Timi Study Group The Efficacy and Safety of Ticagrelor as Compared to Clopidogrel, with and without a Glycoprotein iib/iiia Inhibitor in Patients with Acute Coronary Syndromes Undergoin Percutaneous Intervention: A PLATO (Study of Platelet Inhibition and Patient Outcomes) Analysis Journal of the American College of Cardiology. 2013;61(10):A460.

Bhatt, D. L., Stone, G. W., Mahaffey, K. W., Gibson, C. M., Steg, P. G., Hamm, C. W., Price, M. J., Leonardi, S., Gallup, D., Bramucci, E., Radke, P. W., Widimsky, P., Tousek, F., Tauth, J., Spriggs, D., McLaurin, B. T., Angiolillo, D. J., Genereux, P., Liu, T., Prats, J., Todd, M., Skerjanec, S., White, H. D., Harrington, R. A., Champion Phoenix Investigators Effect of platelet inhibition with cangrelor during PCI on ischemic events N Engl J Med. 2013;368(14):1303-13. Abstract

Bohula May, E. A., Bonaca, M. P., Jarolim, P., Antman, E. M., Braunwald, E., Giugliano, R. P., Newby, L. K., Sabatine, M. S., Morrow, D. A. Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non-ST-Elevation Acute Coronary Syndrome Clin Chem. 2013;NA(NA):NA. Abstract

Bohula May, E. A., Scirica, B., Bonaca, M., Murphy, S., Braunwald, E. B., Morrow, D., Brigham and Women's Hospital Prognostic Value of High-Sensitivity CRP for Cardiovascular Outcomes in TRA 2P - TIMI 50 Journal of the American College of Cardiology. 2013;61(10):A287.

Bonaca, Marc P, Scirica, Benjamin M, Braunwald, Eugene, Wiviott, Stephen D, Murphy, Sabina A, Morrow, David A Abstract 18928: Vorapaxar Reduces Coronary Stent Thrombosis: Results From the TRA2P-TIMI 50 Trial Circulation. 2013;128(22 Supplement):A18928.

Buyukkaya, E., Poyraz, F., Karakas, M. F., Kurt, M., Akcay, A. B., Akpinar, I., Motor, S., Turak, O., Ozturk, O. H., Sen, N., Akpek, M., Kaya, M. G., Gibson, C. M. Usefulness of Monocyte Chemoattractant Protein-1 to Predict No-Reflow and Three-Year Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Am J Cardiol. 2013;NA(NA):NA. Abstract

Carreras, Edward T, Hochholzer, Willibald, Frelinger, Andrew L, Hoffman, Elaine B, O'Donoghue, Michelle L, Wiviott, Stephen D, Angiolillo, Dominick J, Michelson, Alan D, Sabatine, Marc S, Mega, Jessica L Abstract 12325: Diabetes Mellitus, CYP2C19 Genotype, and Pharmacodynamic Response to Clopidogrel Dosing: Insights From the ELEVATE-TIMI 56 Trial Circulation. 2013;128(22 Supplement):A12325.

Cavender, M. A., Braunwald, E. B., Gibson, C. M., Wiviott, S., Murphy, S., Amuchastegui, A., Ophuis, A. J, van Hessen, M, Mega, J. L., Timi Study Group Rivaroxaban Reduces Spontaneous and Large Myocardial Infarctions: findings from the ATLAS ACS 2 - TIMI 51 Trial Journal of the American College of Cardiology. 2013;61(10):A1.

Cavender, M. A., Rajeswaran, J., Di Paola, L., Houghtaling, P., Kiernan, M. S., Rassi, A. N., Menon, V., Whitlow, P. W., Ellis, S. G., Shishehbor, M. H. Outcomes of Culprit Versus Multivessel PCI in Patients With Multivessel Coronary Artery Disease Presenting With ST-Elevation Myocardial Infarction Complicated by Shock J Invasive Cardiol. 2013;25(5):218-24. Abstract

Cavender, Matthew A, Scirica, Benjamin M, Raz, Itamar, Steg, P. G, Hirshberg, Boaz, Davidson, Jaime, Im, KyungAh, Hoffman, Elaine, Braunwald, Eugene, Bhatt, Deepak L Abstract 17270: Outcomes of Patients With Type 2 Diabetes at High Risk of Cardiovascular Events Treated With Saxagliptin: Outcomes by Baseline HgbA1c Circulation. 2013;128(22 Supplement):A17270.

Cavender, Matthew A, Scirica, Benjamin, Bonaca, Marc P, Morais, Joao, Oude Ophius, Ton, Dalby, Tony, Murphy, Sabina, Braunwald, Eugene, Morrow, David Abstract 10398: Vorapaxar in Patients With Diabetes and Prior MI: Findings From the TRA 2P - TIMI 50 Trial Circulation. 2013;128(22 Supplement):A10398.

Chakrabarti, A. K., Feeney, K., Abueg, C., Brown, D. A., Czyz, E., Tendera, M., Janosi, A., Giugliano, R. P., Kloner, R. A., Weaver, W. D., Bode, C., Godlewski, J., Merkely, B., Gibson, C. M. Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction Am Heart J. 2013;165(4):509-514 e7. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Secco, G. G., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D. Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors Heart Vessels. 2013;NA(NA):NA. Abstract

De Luca, G., Van't Hof, A. W., Huber, K., Gibson, C. M., Bellandi, F., Arntz, H. R., Maioli, M., Noc, M., Zorman, S., Zeymer, U., Gabriel, H. M., Emre, A., Cutlip, D., Rakowski, T., Gyongyosi, M., Dudek, D., Egypt cooperation Impact of Hypertension on Distal Embolization, Myocardial Perfusion, and Mortality in Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty Am J Cardiol. 2013;112(8):1083-1086. Abstract

Feres, F., Costa, R. A., Abizaid, A., Leon, M. B., Marin-Neto, J. A., Botelho, R. V., King, S. B., 3rd, Negoita, M., Liu, M., de Paula, J. E., Mangione, J. A., Meireles, G. X., Castello, H. J., Jr., Nicolela, E. L., Jr., Perin, M. A., Devito, F. S., Labrunie, A., Salvadori, D., Jr., Gusmao, M., Staico, R., Costa, J. R., Jr., de Castro, J. P., Abizaid, A. S., Bhatt, D. L., for the, Optimize Trial Investigators Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial JAMA. 2013;NA(NA):NA. Abstract

Ferreiro, J. L., Bhatt, D. L., Ueno, M., Bauer, D., Angiolillo, D. J. Impact of Smoking on Long-Term Outcomes in Patients with Atherosclerotic Vascular Disease Treated with Aspirin or Clopidogrel: Insights from the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Geller, B. J., Mega, J. L., Morrow, D. A., Guo, J., Hoffman, E. B., Gibson, C. M., Ruff, C. T. Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial J Thromb Thrombolysis. 2013;NA(NA):NA. Abstract

Genereux, P., Stone, G. W., Harrington, R. A., Gibson, C. M., Steg, P. G., Brener, S. J., Angiolillo, D. J., Price, M. J., Prats, J., Lasalle, L., Liu, T., Todd, M., Skerjanec, S., Hamm, C. W., Mahaffey, K. W., White, H. D., Bhatt, D. L. Impact of Intra-procedural Stent Thrombosis during Percutaneous Coronary Intervention: Insights from the CHAMPION PHOENIX Trial J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Gibson, C. M., Chakrabarti, A. K., Mega, J., Bode, C., Bassand, J. P., Verheugt, F. W., Bhatt, D. L., Goto, S., Cohen, M., Mohanavelu, S., Burton, P., Stone, G., Braunwald, E., Atlas-Acs Timi Investigators Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51 J Am Coll Cardiol. 2013;62(4):286-90. Abstract

Giraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Jr., Giugliano, R. P., James, S. K., Tanguay, J. F., Pollack, C. V., Jr., Harrington, R. A., Braunwald, E., Newby, L. K. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome Am Heart J. 2013;165(6):918-925 e2. Abstract

Grinstein, J., Bonaca, M., Sabatine, M., Jarolim, P., Conrad, M. J., Braunwald, E. B., Giugliano, R. P., Newby, L. K., Morrow, D. A., Timi Study Group, Prognostic Implications of Low-Level Cardiac Troponin Elevation Using the High-Sensitivity Assay for Cardiac Troponin T: Results from EARLY ACS & SEPIA-TIMI 42 Journal of the American College of Cardiology. 2013;61(10):A27.

Hochholzer, W., Giugliano, R. P. Does it make sense to combine statins with other lipid-altering agents following AIM-HIGH, SHARP and ACCORD? Curr Atheroscler Rep. 2013;15(1):290. Abstract

Holmes, M. V., Simon, T., Exeter, H. J., Folkersen, L., Asselbergs, F. W., Guardiola, M., Cooper, J. A., Palmen, J., Hubacek, J. A., Carruthers, K. F., Horne, B. D., Brunisholz, K. D., Mega, J. L., van Iperen, E. P., Li, M., Leusink, M., Trompet, S., Verschuren, J. J., Hovingh, G. K., Dehghan, A., Nelson, C. P., Kotti, S., Danchin, N., Scholz, M., Haase, C. L., Rothenbacher, D., Swerdlow, D. I., Kuchenbaecker, K. B., Staines-Urias, E., Goel, A., Hooft, F. V., Gertow, K., de Faire, U., Panayiotou, A. G., Tremoli, E., Baldassarre, D., Veglia, F., Holdt, L. M., Beutner, F., Gansevoort, R. T., Navis, G. J., Leach, I. M., Breitling, L. P., Brenner, H., Dallmeier, D., Franco-Cereceda, A., Boer, J., Stephens, J. W., Hofker, M. H., Tedgui, A., Hofman, A., Uitterlinden, A. G., Adamkova, V., Pitha, J., Onland-Moret, N. C., Cramer, M. J., Nathoe, H. M., Spiering, W., Klungel, O. H., Kumari, M., Whincup, P. H., Morrow, D. A., Braund, P. S., Hall, A. S., Olsson, A. G., Doevendans, P. A., Trip, M. D., Tobin, M. D., Hamsten, A., Watkins, H., Koenig, W., Nicolaides, A. N., Teupser, D., Day, I. N., Carlquist, J. F., Gaunt, T. R., Ford, I., Sattar, N., Tsimikas, S., Schwartz, G. G., Lawlor, D. A., Morris, R. W., Sandhu, M. S., Poledne, R., Maitland-van der Zee, A. H., Khaw, K. T., Keating, B. J., van der Harst, P., Price, J. F., Mehta, S. R., Yusuf, S., Witteman, J. C., Franco, O. H., Jukema, J. W., de Knijff, P., Tybjaerg-Hansen, A., Rader, D. J., Farrall, M., Samani, J., Kivimaki, M., Fox, K. A., Humphries, S. E., Anderson, J. L., Boekholdt, S. M., Palmer, T. M., Eriksson, P., Pare, G., Hingorani, A. D., Sabatine, M. S., Mallat, Z., Casas, J. P., Talmud, P. J. Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Klutstein, M. W., Westerhout, C. M., Armstrong, P. W., Giugliano, R. P., Lewis, B. S., Gibson, C. M., Lutchmedial, S., Widimsky, P., Steg, P. G., Dalby, A., Zeymer, U., Van de Werf, F., Harrington, R. A., Newby, L. K., Rao, S. V. Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy Am Heart J. 2013;165(4):583-590 e1. Abstract

Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study. Circulation. 2013;127:673-80. Abstract

Kohli, P., Udell, J. A., Murphy, S. A., Cannon, C. P., Antman, E. M., Braunwald, E., Wiviott, S. D. Discharge Aspirin Dose and Clinical Outcomes in Patients with Acute Coronary Syndromes treated with Prasugrel vs. Clopidogrel: An Analysis from the TRITON-TIMI 38 Study J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Kumbhani, D. J., Bavry, A. A., Desai, M. Y., Bangalore, S., Bhatt, D. L. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: An updated meta-analysis of randomized trials J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Kumbhani, D. J., Steg, P. G., Cannon, C. P., Eagle, K. A., Smith, S. C., Jr., Hoffman, E., Goto, S., Ohman, E. M., Bhatt, D. L., R. Eduction of Atherothrombosis for Continued Health Registry Investigators Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis Am J Med. 2013;126(8):693-700 e1. Abstract

Kunadian V, James SK, Wojdyla DM, Zorkun C, Wu J, Storey RF, Steg PG, Katus H, Emanuelsson H, Horrow J, Maya J, Wallentin L, Harrington RA, Gibson CM. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). JACC Cardiovasc Interv. 2013;6:671-83. Abstract

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial Int J Cardiol. 2013;167(6):2580-7. Abstract

Magnani, Giulia, Morrow, David A, Scirica, Benjamin M, Sabatine, Marc S, Murphy, Sabina A, Bonaca, Marc P Abstract 18728: Patterns of Antiplatelet Use in Patients With Stable Atherosclerosis: Insights From the Tra 2{degrees}P-timi 50 Trial Circulation. 2013;128(22 Supplement):A18728.

Mega, J. L., Braunwald, E. B., Murphy, S., Plotnikov, A, Cook-Bruns, N, Aylward, P., Chopra, V., Gao, R., Nicolau, J., Gibson, C. M., Timi Study Group Rivaroxaban in the Settling of continued Dual Antiplatelet Therapy: Findings from the ATLAS ACS 2 - TIMI 51 Trial Journal of the American College of Cardiology. 2013;61(10):A1.

Mega, J. L., Braunwald, E., Wiviott, S. D., Murphy, S. A., Plotnikov, A., Gotcheva, N., Ruda, M., Gibson, C. M. Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2-TIMI 51) Am J Cardiol. 2013;NA(NA):NA. Abstract

Mogabgab, O., Wiviott, S. D., Antman, E. M., Foody, J. M., Wang, T. Y., Sabatine, M. S., Cannon, C. P., Li, S., Giugliano, R. P. Relation Between Time of Symptom Onset of ST-Segment Elevation Myocardial Infarction and Patient Baseline Characteristics: From the National Cardiovascular Data Registry Clin Cardiol. 2013;36(4):222-7. Abstract

Mogabgab, O., Wiviott, S. D., Cannon, C. P., Sloan, S., Sabatine, M. S., Antman, E. M., Braunwald, E., Giugliano, R. P. Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial J Cardiovasc Pharmacol Ther. 2013;NA(NA):NA. Abstract

Mohareb, M., Goodman, S. G., Yan, R. T., Bhatt, D. L., Elbarouni, B., Deyoung, J. P., Gallo, R., Kornder, J. M., Welsh, R. C., Saposnik, G., Rose, B., Wong, G. C., Grondin, F. R., Yan, A. T., on behalf of the Canadian, Grace Grace Canrace investigators Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease Int J Cardiol. 2013;NA(NA):NA. Abstract

Mosenzon, O., Raz, I., Scirica, B. M., Hirshberg, B., Stahre, C. I., Steg, P. G., Davidson, J., Ohman, P., Price, D. L., Frederich, B., Udell, J. A., Braunwald, E., Bhatt, D. L. Baseline characteristics of patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR) - TIMI 53 Trial Diabetes Metab Res Rev. 2013;NA(NA):NA. Abstract

Murphy, S. A., Giugliano, R. P. Atrial fibrillation and prior MI: searching for balance in ischaemic and bleeding events in patients treated with fibrin-specific anticoagulants Eur Heart J. 2013;NA(NA):NA.

Nazer, B., Ray, K. K., Murphy, S. A., Gibson, C. M., Cannon, C. P. Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy J Thromb Thrombolysis. 2013;36(3):233-9. Abstract

Nicholls, S. J., Kastelein, J. J., Schwartz, G. G., Bash, D., Rosenson, R. S., Cavender, M. A., Brennan, D. M., Koenig, W., Jukema, J. W., Nambi, V., Wright, R. S., Menon, V., Lincoff, A. M., Nissen, S. E., for the, Vista-Investigators Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome: The VISTA-16 Randomized Clinical Trial JAMA. 2013;NA(NA):NA. Abstract

O'Donoghue, M., Morrow, D. A., Tsimikas, S., Sloan, S., Ren, A. F., Hoffman, E. B., Desai, N. P., Solomon, S. D., Domanski, M., Arai, K., Chiuve, S. E., Cannon, C. P., Sacks, F. M., Sabatine, M. S. Lipoprotein (a) For Risk Assessment in Patients with Established Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

O'Donoghue, Michelle L, Mega, Jessica L, Braunwald, Eugene, Nicolau, Jose C, Bhatt, Deepak L, Murphy, Sabina A, Gibson, C. Michael Abstract 11382: The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial Circulation. 2013;128(22 Supplement):A11382.

O'Malley, R. G., Sabatine, M. S., Bonaca, M. P., Murphy, S., Jarolim, P., Conrad, M. J., Cannon, C. P., Braunwald, E. B., Morrow, D. A. Prognostic Performance of Srial High Sensitivity Cardiac Troponin Determination in Stable Ischemic Heart Disease: Analysis from PROVE IT-TIMI 22 Journal of the American College of Cardiology. 2013;61(10):A283.

Ojeifo, O., Wiviott, S. D., Antman, E. M., Murphy, S. A., Udell, J. A., Bates, E. R., Mega, J. L., Sabatine, M. S., O'Donoghue, M. L. Concomitant Administration of Clopidogrel With Statins or Calcium Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38) Trial JACC Cardiovasc Interv. 2013;NA(NA):NA. Abstract

Omland, T., Pfeffer, M. A., Solomon, S. D., de Lemos, J. A., Rosjo, H., Saltyte Benth, J., Maggioni, A., Domanski, M. J., Rouleau, J. L., Sabatine, M. S., Braunwald, E., Peace Investigators Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Pride, Y. B., Piccirillo, B. J., Gibson, C. M. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction Am J Cardiol. 2013;111(6):914-8. Abstract

Reed, G. W. Influence of Smoking on the Antiplatelet Effect of Clopidogrel Differs According to Dosing Stragegy: Insights from the GRAVITAS Trial Journal of the American College of Cardiology. 2013;61(10):A475.

Reed, Grant W, Guo, Jianping, Hoffman, Elaine B, Maree, Andrew O, Shekar, Prem, Aranki, Sary, Rosenfield, Kenneth, Cannon, Christopher P Abstract 10331: Aspirin Responsiveness Testing Predicts Bleeding During Coronary Artery Bypass Grafting: The Verify Pre-Op - TIMI 45 Study Circulation. 2013;128(22 Supplement):A10331.

Rose, J. J., Newby, L. K., Broderick, S., Chiswell, K., Van de Werf, F., Armstrong, P. W., Mahaffey, K. W., Harrington, R. A., Ohman, E. M., Giugliano, R. P., Goodman, S. G., White, H. D., Califf, R. M., Granger, C. B., Lopes, R. D. Left Bundle Branch Block in Non-ST-Segment Elevation Acute Coronary Syndromes: Incidence, Angiographic Characteristics, and Clinical Outcomes J Am Coll Cardiol. 2013;61(13):1461-3.

Ruff, C. T., Moryusef, A, Umez-Eronini, A., Hoffman, Elain P., Gaudin, C., Antman, E., Sabatine, M., Timi Study Group Evaluation of the Efficacy and Safety of Otamixaban versus Unfractionated Heparin+Eptifibatide in Patients with Non-ST-Elevation Acute Coronary Syndromes by PCI in the SEPIA-ACS1 TIMI 42 Trial Journal of the American College of Cardiology. 2013;61(10):A25.

Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I; SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. N Engl J Med. 2013;369:1317-1326. Abstract

Scirica, B. M., Kadakia, M. B., de Lemos, J. A., Roe, M. T., Morrow, D. A., Li, S., Wiviott, S. D., Kontos, M. C., on behalf of the National Cardiovascular Data, Registry Association between Natriuretic Peptides and Mortality among Patients Admitted with Myocardial Infarction: A Report from the ACTION Registry(R)-GWTG Clin Chem. 2013;NA(NA):NA. Abstract

Scirica, B., Nieminen, T., Pegler, J. R. M., Tavares, C., Pagotto, V. P. F., Kanas, A. F., Sobrado, M. F., Nearing, B., Cho, J. I., Morrow, D., Belardinelli, L., Verrier, R., Harvard Medical School T-Wave Alternans (TWA) is Associated with Cardiovascular Mortality and NSVTin the MERLIN-TIMI 36 Trial of Ranolazine versus Placebo in Patients with Non-ST Segment Elevation Acute Coronary Syndrome Journal of the American College of Cardiology. 2013;61(10):64.

Sirimarco, G., Amarenco, P., Labreuche, J., Touboul, P. J., Alberts, M., Goto, S., Rother, J., Mas, J. L., Bhatt, D. L., Steg, P. G., Reach Registry Investigators Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis Stroke. 2013;44:373-9. Abstract

Smith, S. W., Diercks, D. B., Nagurney, J. T., Hollander, J. E., Miller, C. D., Schrock, J. W., Singer, A. J., Apple, F. S., McCullough, P. A., Ruff, C. T., Sesma, A., Jr., Peacock, W. F. Central versus local adjudication of myocardial infarction in a cardiac biomarker trial Am Heart J. 2013;165(3):273-279 e1. Abstract

Steen, Dylan L, Umez-Eronini, Amarachi A, Hoffman, Elaine B, Antman, Elliott M, Wiviott, Stephen D Abstract 17544: Utilization of Intensive Lipid-Lowering Therapy After an Acute Coronary Syndrome: Insights From the Triton-TIMI 38 Trial Circulation. 2013;128(22 Supplement):A17544.

Steg, P. G., Bhatt, D. L., Hamm, C. W., Stone, G. W., Gibson, C. M., Mahaffey, K. W., Leonardi, S., Liu, T., Skerjanec, S., Day, J. R., Iwaoka, R. S., Stuckey, T. D., Gogia, H. S., Gruberg, L., French, W. J., White, H. D., Harrington, R. A. Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data Lancet. 2013;NA(NA):NA. Abstract

Steg, P. G., Mehta, S. R., Pollack, C. V., Jr., Bode, C., Cohen, M., French, W. J., Hoekstra, J., Rao, S. V., Ruzyllo, W., Ruiz-Nodar, J. M., Sabate, M., Widimsky, P., Kiss, R. G., Navarro Estrada, J. L., Hod, H., Kerkar, P., Guneri, S., Sezer, M., Ruda, M., Nicolau, J. C., Cavallini, C., Ebrahim, I., Petrov, I., Kim, J. H., Jeong, M. H., Ramos Lopez, G. A., Laanmets, P., Kovar, F., Gaudin, C., Fanouillere, K. C., Minini, P., Hoffman, E. B., Moryusef, A., Wiviott, S. D., Sabatine, M. S., T. A. O. Investigators Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial JAMA. 2013;310(11):1145-55. Abstract

Storey RF, James SK, Siegbahn A, Varenhorst C, Held C, Ycas J, Husted SE, Cannon CP, Becker RC, Steg PG, Åsenblad N, Wallentin L. Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study. Platelets. 2013;25:517-25. Abstract

Tantry, U. S., Bonello, L., Aradi, D., Price, M. J., Jeong, Y. H., Angiolillo, D. J., Stone, G. W., Curzen, N., Geisler, T., Ten Berg, J., Kirtane, A., Siller-Matula, J., Mahla, E., Becker, R. C., Bhatt, D. L., Waksman, R., Rao, S. V., Alexopoulos, D., Marcucci, R., Reny, J. L., Trenk, D., Sibbing, D., Gurbel, P. A. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to ADP Associated with Ischemia and Bleeding J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Tricoci, P., Leonardi, S., White, J., White, H. D., Armstrong, P. W., Montalescot, G., Giugliano, R. P., Gibson, C. M., Van de Werf, F., Califf, R. M., Harrington, R. A., Braunwald, E., Mahaffey, K. W., Newby, L. K. Cardiac Troponin after Percutaneous Coronary Intervention and 1-Year Mortality in NSTE ACS Using Systematic Evaluation of Biomarker Trends J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Truong, Q. A., Hayden, D. L., Woodard, P. K., Kirby, R., Chou, E. T., Nagurney, J. T., Wiviott, S. D., Fleg, J. L., Schoenfeld, D. A., Udelson, J. E., Hoffmann, U. Sex Differences in the Effectiveness of Early Coronary CT Angiography Compared to Standard Emergency Department Evaluation for Acute Chest Pain: The ROMICAT II Trial Circulation. 2013;NA(NA):NA. Abstract

Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., Cannon, C. P. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JAMA. 2013;310(16):1711-20. Abstract

Udell, Jacob A, Bhatt, Deepak L, Hoffman, Elaine B, Cannon, Christopher P Abstract 10286: Benefit of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes After Recent Influenza-like Illness: Results From the PROVE IT-TIMI 22 Trial Circulation. 2013;128(22 Supplement):A10286.

Udell, Jacob A, Morrow, David A, Jarolim, Petr, Sloan, Sarah, Hoffman, Elaine B, O'Donnell, Thomas F, Vora, Amit V, Omland, Torbjorn, Solomon, Scott D, Pfeffer, Marc A, Braunwald, Eugene, Sabatine, Marc S Abstract 10291: Fibroblast Growth Factor (FGF)-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease Circulation. 2013;128(22 Supplement):A10291.

White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., Wilson, C., Cushman, W. C., Zannad, F. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes N Engl J Med. 2013;NA(NA):NA. Abstract

Wiviott, S. D., White, H. D., Ohman, E. M., Fox, K. A., Armstrong, P. W., Prabhakaran, D., Hafley, G., Lokhnygina, Y., Boden, W. E., Hamm, C., Clemmensen, P., Nicolau, J. C., Menozzi, A., Ruzyllo, W., Widimsky, P., Oto, A., Leiva-Pons, J., Pavlides, G., Winters, K. J., Roe, M. T., Bhatt, D. L. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial Lancet. 2013;382(9892):605-13. Abstract

Bonaca MP, Bhatt DL, Braunwald E, Cohen M, Steg PG, Storey RF, Held P, Jensen EC, Sabatine MS Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. Am Heart J. 2014;167:437-444. Abstract

Bonaca, M. P., Murphy, S. A., Miller, D., Herrman, J. P., Gottlieb, S., Keltai, M., Menozzi, A., Nicolau, J. C., Widimsky, P., Antman, E. M., Wiviott, S. D. Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry Clin Cardiol. 2014;NA(NA):NA. Abstract

Bui, An, Cannon, Christopher, Steg, Philippe, Storey, Robert, Husted, Steen, Ren, Fang, James, Stefan, Michelson, Eric, Himmelmann, Anders, Wallentin, Lars, Scirica, Benjamin RISK OF CARDIOVASCULAR DEATH AND NON-SUSTAINED VENTRICULAR TACHYCARDIA DETECTED 30-DAYS AFTER ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL Journal of the American College of Cardiology. 2014;63(12, Supplement):A298.

Cavender, Matthew, Steg, Philippe, Smith, Sidney, Eagle, Kim, Ohman, Erik, Goto, Shinya, Kuder, Julia, Im, Kyungah, Bhatt, Deepak Cardiovascular Event Rates in Patients with Diabetes: Insights from the International Reach Registry Journal of the American College of Cardiology. 2014;63(12, Supplement):A1340.

Kato, Eri Toda, Bonaca, Marc, Morrow, David, Jarolim, Petr, Sloan, Sarah, Solomon, Scott, Braunwald, Eugene, Sabatine, Marc GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) AND THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Journal of the American College of Cardiology. 2014;63(12, Supplement):A1525.

Kidd, Stephen, Bonaca, Marc, Scirica, Benjamin, Murphy, Sabina, Braunwald, Eugene, Morrow, David UNIVERSAL CLASSIFICATION SYSTEM TYPE OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ATHEROSCLEROSIS: OBSERVATIONS FROM TRA 2°P-TIMI 50 Journal of the American College of Cardiology. 2014;63(12, Supplement):A1568.

Kumbhani, D. J., Bavry, A. A., Desai, M. Y., Bangalore, S., Byrne, R. A., Jneid, H., Bhatt, D. L. Aspiration thrombectomy in patients undergoing primary angioplasty: Totality of data to 2013 Catheter Cardiovasc Interv. 2014;NA(NA):NA. Abstract

Kunadian, V., Giugliano, R. P., Newby, L. K., Zorkun, C., Guo, J., Bagai, A., Montalescot, G., Braunwald, E., Califf, R. M., Van de Werf, F., Armstrong, P. W., Harrington, R., Gibson, C. M. Angiographic Outcomes With Early Eptifibatide Therapy in Non-ST-Segment Elevation Acute Coronary Syndrome (from the EARLY ACS Trial) Am J Cardiol. 2014;113(8):1297-305. Abstract

Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, Husted S, Steg PG, Cornel JH, Storey RF, Stevens SR, Wallentin L, James SK. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35:2083-93. Abstract

May, Erin Ann Bohula, Bonaca, Marc, Scirica, Benjamin, Kuder, Julia, Murphy, Sabina, Jarolim, Petr, Sabatine, Marc, Morrow, David GROWTH DIFFERENTIATION FACTOR-15 LEVEL PREDICTS RECURRENT CARDIOVASCULAR EVENTS IN PATIENTS WITH AN ACUTE CORONARY SYNDROME IN MERLIN-TIMI 36 Journal of the American College of Cardiology. 2014;63(12, Supplement):A20.

Nieminen, T., Scirica, B. M., Pegler, J. R., Tavares, C., Pagotto, V. P., Kanas, A. F., Sobrado, M. F., Nearing, B. D., Umez-Eronini, A. A., Morrow, D. A., Belardinelli, L., Verrier, R. L. Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo Am J Cardiol. 2014;NA(NA):NA. Abstract

O'Malley, R. G., Bonaca, M. P., Scirica, B. M., Murphy, S. A., Jarolim, P., Sabatine, M. S., Braunwald, E., Morrow, D. A. Prognostic Performance of Multiple Biomarkers in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN-TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36) J Am Coll Cardiol. 2014;63(16):1644-53. Abstract

Rhee, J. W., Wiviott, S. D., Scirica, B. M., Gibson, C. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A., Mega, J. L. Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Syndrome Clin Cardiol. 2014;NA(NA):NA. Abstract

Scirica, Benjamin, Bhatt, Deepak, Braunwald, Eugene, Raz, Itamar, Steg, Philippe, Davidson, Jaime, Cavender, Matthew, Hirshberg, Boaz, Umez-Eronini, Amarachi, Im, Kelly, Jarolim, Petr, Morrow, David Prognostic Implications of Simultaneous Biomarker Assessments in Patients with Type 2 Diabetes Mellitus: Observations from the SAVOR-TIMI 53 TRIAL Journal of the American College of Cardiology. 2014;63(12, Supplement):A1550.

Sherwood, M. W., Wiviott, S. D., Peng, S. A., Roe, M. T., Delemos, J., Peterson, E. D., Wang, T. Y. Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry J Am Heart Assoc. 2014;3(2):e000849. Abstract

Timur, A. A., Murugesan, G., Zhang, L., Barnard, J., Bhatt, D. L., Kottke-Marchant, K. Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy Thromb Res. 2014;NA(NA):NA. Abstract

Udell, J. A., Morrow, D. A., Jarolim, P., Sloan, S., Hoffman, E. B., O'Donnell, T. F., Vora, A. N., Omland, T., Solomon, S. D., Pfeffer, M. A., Braunwald, E., Sabatine, M. S. Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease J Am Coll Cardiol. 2014;NA(NA):NA. Abstract

Udell, Jacob A., Scirica, Benjamin, Cavender, Matthew A., Mosenzon, Ofri, Steg, Philippe, Davidson, Jaime, Hirshberg, Boaz, Im, Kyungah, Raz, Itamar, Bhatt, Deepak Baseline Renal Function and Cardiovascular Risk in Patients Treated with Saxagliptin: Observations from the SAVOR-TIMI 53 TRIAL Journal of the American College of Cardiology. 2014;63(12, Supplement):A1523.

Waks, J. W., Sabatine, M. S., Cannon, C. P., Morrow, D. A., Gibson, C. M., Wiviott, S. D., Giugliano, R. P., Sloan, S., Scirica, B. M. Clinical Implications and Correlates of Q Waves in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY-TIMI 28 Trial Clin Cardiol. 2014;37(3):160-6. Abstract

Desai, Nihar, Peterson, E., Chen, A., Wiviott, S., Sabatine, M., Alexander, K. P., Roe, M., Shah, B. Balancing the Risk of Mortality and Major Bleeding in the Treatment of NSTEMI Patients – A Report from the NCDR American Heart Journal. NA;NA(NA):NA.